KR102388736B1 - Method for removing residual pesticide in natural plant extract by three stage treatment - Google Patents
Method for removing residual pesticide in natural plant extract by three stage treatment Download PDFInfo
- Publication number
- KR102388736B1 KR102388736B1 KR1020210167489A KR20210167489A KR102388736B1 KR 102388736 B1 KR102388736 B1 KR 102388736B1 KR 1020210167489 A KR1020210167489 A KR 1020210167489A KR 20210167489 A KR20210167489 A KR 20210167489A KR 102388736 B1 KR102388736 B1 KR 102388736B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- oil
- layer
- red ginseng
- extract
- Prior art date
Links
- 239000000575 pesticide Substances 0.000 title claims abstract description 49
- 238000000034 method Methods 0.000 title claims abstract description 18
- 239000000419 plant extract Substances 0.000 title description 2
- 241000208340 Araliaceae Species 0.000 claims abstract description 75
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 75
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 75
- 235000008434 ginseng Nutrition 0.000 claims abstract description 75
- 239000012141 concentrate Substances 0.000 claims abstract description 56
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 24
- 239000000194 fatty acid Substances 0.000 claims abstract description 24
- 229930195729 fatty acid Natural products 0.000 claims abstract description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 19
- -1 glycerin fatty acid ester Chemical class 0.000 claims abstract description 19
- 235000011187 glycerol Nutrition 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 235000002789 Panax ginseng Nutrition 0.000 claims description 89
- 239000003921 oil Substances 0.000 claims description 62
- 235000019198 oils Nutrition 0.000 claims description 62
- 235000020710 ginseng extract Nutrition 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000828 canola oil Substances 0.000 claims description 16
- 235000019519 canola oil Nutrition 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 16
- 239000003240 coconut oil Substances 0.000 claims description 8
- 235000019864 coconut oil Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 244000104275 Phoenix dactylifera Species 0.000 claims description 7
- 235000010659 Phoenix dactylifera Nutrition 0.000 claims description 7
- 239000002540 palm oil Substances 0.000 claims description 7
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims 1
- 241000723346 Cinnamomum camphora Species 0.000 claims 1
- 229960000846 camphor Drugs 0.000 claims 1
- 229930008380 camphor Natural products 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 abstract description 17
- 239000008157 edible vegetable oil Substances 0.000 abstract description 8
- 239000000284 extract Substances 0.000 description 49
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 39
- 238000002360 preparation method Methods 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 238000012545 processing Methods 0.000 description 15
- 239000007788 liquid Substances 0.000 description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000000447 pesticide residue Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 239000008213 purified water Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 6
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 6
- 239000004695 Polyether sulfone Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 229920002301 cellulose acetate Polymers 0.000 description 5
- 239000008162 cooking oil Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 150000002314 glycerols Chemical class 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 5
- 125000005498 phthalate group Chemical class 0.000 description 5
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 5
- 229920006393 polyether sulfone Polymers 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000607479 Yersinia pestis Species 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000010422 internal standard material Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 3
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 3
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 3
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 3
- JLYFCTQDENRSOL-UHFFFAOYSA-N 2-chloro-N-(2,4-dimethylthiophen-3-yl)-N-(1-methoxypropan-2-yl)acetamide Chemical compound COCC(C)N(C(=O)CCl)C=1C(C)=CSC=1C JLYFCTQDENRSOL-UHFFFAOYSA-N 0.000 description 3
- CTSLUCNDVMMDHG-UHFFFAOYSA-N 5-bromo-3-(butan-2-yl)-6-methylpyrimidine-2,4(1H,3H)-dione Chemical compound CCC(C)N1C(=O)NC(C)=C(Br)C1=O CTSLUCNDVMMDHG-UHFFFAOYSA-N 0.000 description 3
- 239000005875 Acetamiprid Substances 0.000 description 3
- 239000005730 Azoxystrobin Substances 0.000 description 3
- 239000005874 Bifenthrin Substances 0.000 description 3
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 3
- 239000005892 Deltamethrin Substances 0.000 description 3
- 239000005759 Diethofencarb Substances 0.000 description 3
- 239000005760 Difenoconazole Substances 0.000 description 3
- 239000005776 Fenhexamid Substances 0.000 description 3
- 239000005781 Fludioxonil Substances 0.000 description 3
- 239000005782 Fluopicolide Substances 0.000 description 3
- 239000005786 Flutolanil Substances 0.000 description 3
- 239000005800 Kresoxim-methyl Substances 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- 239000005807 Metalaxyl Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000005869 Pyraclostrobin Substances 0.000 description 3
- 239000005828 Pyrimethanil Substances 0.000 description 3
- 239000005839 Tebuconazole Substances 0.000 description 3
- 239000005939 Tefluthrin Substances 0.000 description 3
- 239000005941 Thiamethoxam Substances 0.000 description 3
- YIJZJEYQBAAWRJ-UHFFFAOYSA-N Thiazopyr Chemical compound N1=C(C(F)F)C(C(=O)OC)=C(CC(C)C)C(C=2SCCN=2)=C1C(F)(F)F YIJZJEYQBAAWRJ-UHFFFAOYSA-N 0.000 description 3
- 239000005623 Thifensulfuron-methyl Substances 0.000 description 3
- 239000005857 Trifloxystrobin Substances 0.000 description 3
- 239000005858 Triflumizole Substances 0.000 description 3
- QGLZXHRNAYXIBU-WEVVVXLNSA-N aldicarb Chemical compound CNC(=O)O\N=C\C(C)(C)SC QGLZXHRNAYXIBU-WEVVVXLNSA-N 0.000 description 3
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 3
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 3
- KXRPCFINVWWFHQ-UHFFFAOYSA-N cadusafos Chemical compound CCC(C)SP(=O)(OCC)SC(C)CC KXRPCFINVWWFHQ-UHFFFAOYSA-N 0.000 description 3
- 239000006013 carbendazim Substances 0.000 description 3
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 3
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 3
- 229960002483 decamethrin Drugs 0.000 description 3
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 3
- LNJNFVJKDJYTEU-UHFFFAOYSA-N diethofencarb Chemical compound CCOC1=CC=C(NC(=O)OC(C)C)C=C1OCC LNJNFVJKDJYTEU-UHFFFAOYSA-N 0.000 description 3
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- VDLGAVXLJYLFDH-UHFFFAOYSA-N fenhexamid Chemical compound C=1C=C(O)C(Cl)=C(Cl)C=1NC(=O)C1(C)CCCCC1 VDLGAVXLJYLFDH-UHFFFAOYSA-N 0.000 description 3
- MUJOIMFVNIBMKC-UHFFFAOYSA-N fludioxonil Chemical compound C=12OC(F)(F)OC2=CC=CC=1C1=CNC=C1C#N MUJOIMFVNIBMKC-UHFFFAOYSA-N 0.000 description 3
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 description 3
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 description 3
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229960000490 permethrin Drugs 0.000 description 3
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 3
- QXJKBPAVAHBARF-BETUJISGSA-N procymidone Chemical compound O=C([C@]1(C)C[C@@]1(C1=O)C)N1C1=CC(Cl)=CC(Cl)=C1 QXJKBPAVAHBARF-BETUJISGSA-N 0.000 description 3
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 3
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- AWYOMXWDGWUJHS-UHFFFAOYSA-N tebupirimfos Chemical compound CCOP(=S)(OC(C)C)OC1=CN=C(C(C)(C)C)N=C1 AWYOMXWDGWUJHS-UHFFFAOYSA-N 0.000 description 3
- NWWZPOKUUAIXIW-FLIBITNWSA-N thiamethoxam Chemical compound [O-][N+](=O)\N=C/1N(C)COCN\1CC1=CN=C(Cl)S1 NWWZPOKUUAIXIW-FLIBITNWSA-N 0.000 description 3
- AHTPATJNIAFOLR-UHFFFAOYSA-N thifensulfuron-methyl Chemical group S1C=CC(S(=O)(=O)NC(=O)NC=2N=C(OC)N=C(C)N=2)=C1C(=O)OC AHTPATJNIAFOLR-UHFFFAOYSA-N 0.000 description 3
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- ONCZDRURRATYFI-TVJDWZFNSA-N trifloxystrobin Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-TVJDWZFNSA-N 0.000 description 3
- HSMVPDGQOIQYSR-KGENOOAVSA-N triflumizole Chemical compound C1=CN=CN1C(/COCCC)=N/C1=CC=C(Cl)C=C1C(F)(F)F HSMVPDGQOIQYSR-KGENOOAVSA-N 0.000 description 3
- NZYBILDYPCVNMU-UHFFFAOYSA-N 3-phenylpiperidine Chemical compound C1CCNCC1C1=CC=CC=C1 NZYBILDYPCVNMU-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QSGNQELHULIMSJ-POHAHGRESA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] dimethyl phosphate Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl QSGNQELHULIMSJ-POHAHGRESA-N 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000012482 calibration solution Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000002552 multiple reaction monitoring Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 2
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N γ Benzene hexachloride Chemical compound ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 2
- YNWVFADWVLCOPU-MDWZMJQESA-N (1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1 YNWVFADWVLCOPU-MDWZMJQESA-N 0.000 description 1
- ZXFXBSWRVIQKOD-AQTZKLSLSA-N (1R,2R,3S,5S,6R,7S,8S)-1,6,8,9,10,11,11-heptachloro-4-oxatetracyclo[6.2.1.02,7.03,5]undec-9-ene Chemical compound ClC1=C(Cl)[C@]2(Cl)[C@H]3[C@@H]4O[C@@H]4[C@H](Cl)[C@H]3[C@@]1(Cl)C2(Cl)Cl ZXFXBSWRVIQKOD-AQTZKLSLSA-N 0.000 description 1
- VIXCLRUCUMWJFF-KGLIPLIRSA-N (1R,5S)-benzobicyclon Chemical compound CS(=O)(=O)c1ccc(C(=O)C2=C(Sc3ccccc3)[C@H]3CC[C@H](C3)C2=O)c(Cl)c1 VIXCLRUCUMWJFF-KGLIPLIRSA-N 0.000 description 1
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 1
- PGOOBECODWQEAB-UHFFFAOYSA-N (E)-clothianidin Chemical compound [O-][N+](=O)\N=C(/NC)NCC1=CN=C(Cl)S1 PGOOBECODWQEAB-UHFFFAOYSA-N 0.000 description 1
- ADDQHLREJDZPMT-AWEZNQCLSA-N (S)-metamifop Chemical compound O=C([C@@H](OC=1C=CC(OC=2OC3=CC(Cl)=CC=C3N=2)=CC=1)C)N(C)C1=CC=CC=C1F ADDQHLREJDZPMT-AWEZNQCLSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- RMOGWMIKYWRTKW-UONOGXRCSA-N (S,S)-paclobutrazol Chemical compound C([C@@H]([C@@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1 RMOGWMIKYWRTKW-UONOGXRCSA-N 0.000 description 1
- HOKKPVIRMVDYPB-UVTDQMKNSA-N (Z)-thiacloprid Chemical compound C1=NC(Cl)=CC=C1CN1C(=N/C#N)/SCC1 HOKKPVIRMVDYPB-UVTDQMKNSA-N 0.000 description 1
- OVXMBIVWNJDDSM-UHFFFAOYSA-N (benzhydrylideneamino) 2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoate Chemical compound COC1=CC(OC)=NC(OC=2C(=C(OC=3N=C(OC)C=C(OC)N=3)C=CC=2)C(=O)ON=C(C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 OVXMBIVWNJDDSM-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- VGPIBGGRCVEHQZ-UHFFFAOYSA-N 1-(biphenyl-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC(C=C1)=CC=C1C1=CC=CC=C1 VGPIBGGRCVEHQZ-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- PZBPKYOVPCNPJY-UHFFFAOYSA-N 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=C)CN1C=NC=C1 PZBPKYOVPCNPJY-UHFFFAOYSA-N 0.000 description 1
- IXWKBUKANTXHJH-UHFFFAOYSA-N 1-[5-chloro-2-methyl-4-(5-methyl-5,6-dihydro-1,4,2-dioxazin-3-yl)pyrazol-3-yl]sulfonyl-3-(4,6-dimethoxypyrimidin-2-yl)urea Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N(N=C(Cl)C=2C=2OC(C)CON=2)C)=N1 IXWKBUKANTXHJH-UHFFFAOYSA-N 0.000 description 1
- CVUGPAFCQJIYDT-UHFFFAOYSA-N 1-chloro-2-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=CC=C1Cl CVUGPAFCQJIYDT-UHFFFAOYSA-N 0.000 description 1
- PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- KWLVWJPJKJMCSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-N-{2-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]ethyl}-2-(prop-2-yn-1-yloxy)acetamide Chemical compound C1=C(OCC#C)C(OC)=CC(CCNC(=O)C(OCC#C)C=2C=CC(Cl)=CC=2)=C1 KWLVWJPJKJMCSH-UHFFFAOYSA-N 0.000 description 1
- YABFPHSQTSFWQB-UHFFFAOYSA-N 2-(4-fluorophenyl)-1-(1,2,4-triazol-1-yl)-3-(trimethylsilyl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(O)(C[Si](C)(C)C)CN1C=NC=N1 YABFPHSQTSFWQB-UHFFFAOYSA-N 0.000 description 1
- GOCUAJYOYBLQRH-UHFFFAOYSA-N 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC=C(C(F)(F)F)C=C1Cl GOCUAJYOYBLQRH-UHFFFAOYSA-N 0.000 description 1
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 description 1
- WVQBLGZPHOPPFO-UHFFFAOYSA-N 2-chloro-N-(2-ethyl-6-methylphenyl)-N-(1-methoxypropan-2-yl)acetamide Chemical compound CCC1=CC=CC(C)=C1N(C(C)COC)C(=O)CCl WVQBLGZPHOPPFO-UHFFFAOYSA-N 0.000 description 1
- KZNDFYDURHAESM-UHFFFAOYSA-N 2-chloro-n-(2-ethyl-6-methylphenyl)-n-(propan-2-yloxymethyl)acetamide Chemical compound CCC1=CC=CC(C)=C1N(COC(C)C)C(=O)CCl KZNDFYDURHAESM-UHFFFAOYSA-N 0.000 description 1
- SOUGWDPPRBKJEX-UHFFFAOYSA-N 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide Chemical compound ClCC(=O)C(C)(CC)NC(=O)C1=CC(Cl)=C(C)C(Cl)=C1 SOUGWDPPRBKJEX-UHFFFAOYSA-N 0.000 description 1
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- XTDZGXBTXBEZDN-UHFFFAOYSA-N 3-(difluoromethyl)-N-(9-isopropyl-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl)-1-methylpyrazole-4-carboxamide Chemical compound CC(C)C1C2CCC1C1=C2C=CC=C1NC(=O)C1=CN(C)N=C1C(F)F XTDZGXBTXBEZDN-UHFFFAOYSA-N 0.000 description 1
- NMWKWBPNKPGATC-UHFFFAOYSA-N 4,5,6,7-tetrachloro-2-benzofuran-1(3H)-one Chemical compound ClC1=C(Cl)C(Cl)=C2COC(=O)C2=C1Cl NMWKWBPNKPGATC-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- XJFIKRXIJXAJGH-UHFFFAOYSA-N 5-chloro-1,3-dihydroimidazo[4,5-b]pyridin-2-one Chemical group ClC1=CC=C2NC(=O)NC2=N1 XJFIKRXIJXAJGH-UHFFFAOYSA-N 0.000 description 1
- PCCSBWNGDMYFCW-UHFFFAOYSA-N 5-methyl-5-(4-phenoxyphenyl)-3-(phenylamino)-1,3-oxazolidine-2,4-dione Chemical compound O=C1C(C)(C=2C=CC(OC=3C=CC=CC=3)=CC=2)OC(=O)N1NC1=CC=CC=C1 PCCSBWNGDMYFCW-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 239000005652 Acrinathrin Substances 0.000 description 1
- XKJMBINCVNINCA-UHFFFAOYSA-N Alfalone Chemical compound CON(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XKJMBINCVNINCA-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000005726 Ametoctradin Substances 0.000 description 1
- 239000005727 Amisulbrom Substances 0.000 description 1
- NXQDBZGWYSEGFL-UHFFFAOYSA-N Anilofos Chemical compound COP(=S)(OC)SCC(=O)N(C(C)C)C1=CC=C(Cl)C=C1 NXQDBZGWYSEGFL-UHFFFAOYSA-N 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000005469 Azimsulfuron Substances 0.000 description 1
- 239000005472 Bensulfuron methyl Substances 0.000 description 1
- 239000005484 Bifenox Substances 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- VEDTXTNSFWUXGQ-UHFFFAOYSA-N Carbophenothion Chemical compound CCOP(=S)(OCC)SCSC1=CC=C(Cl)C=C1 VEDTXTNSFWUXGQ-UHFFFAOYSA-N 0.000 description 1
- 239000005746 Carboxin Substances 0.000 description 1
- 239000005492 Carfentrazone-ethyl Substances 0.000 description 1
- 239000005886 Chlorantraniliprole Substances 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- 239000005647 Chlorpropham Substances 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 239000005945 Chlorpyrifos-methyl Substances 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 239000005887 Chromafenozide Substances 0.000 description 1
- 239000005497 Clethodim Substances 0.000 description 1
- 239000005654 Clofentezine Substances 0.000 description 1
- 239000005499 Clomazone Substances 0.000 description 1
- 239000005888 Clothianidin Substances 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 239000005754 Cyazofamid Substances 0.000 description 1
- OFSLKOLYLQSJPB-UHFFFAOYSA-N Cyclosulfamuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)NC=2C(=CC=CC=2)C(=O)C2CC2)=N1 OFSLKOLYLQSJPB-UHFFFAOYSA-N 0.000 description 1
- 239000005755 Cyflufenamid Substances 0.000 description 1
- 239000005502 Cyhalofop-butyl Substances 0.000 description 1
- TYIYMOAHACZAMQ-CQSZACIVSA-N Cyhalofop-butyl Chemical group C1=CC(O[C@H](C)C(=O)OCCCC)=CC=C1OC1=CC=C(C#N)C=C1F TYIYMOAHACZAMQ-CQSZACIVSA-N 0.000 description 1
- 239000005756 Cymoxanil Substances 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- 239000005758 Cyprodinil Substances 0.000 description 1
- NNYRZQHKCHEXSD-UHFFFAOYSA-N Daimuron Chemical compound C1=CC(C)=CC=C1NC(=O)NC(C)(C)C1=CC=CC=C1 NNYRZQHKCHEXSD-UHFFFAOYSA-N 0.000 description 1
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- IKYICRRUVNIHPP-UHFFFAOYSA-N Dimethametryn Chemical compound CCNC1=NC(NC(C)C(C)C)=NC(SC)=N1 IKYICRRUVNIHPP-UHFFFAOYSA-N 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- QAHFOPIILNICLA-UHFFFAOYSA-N Diphenamid Chemical compound C=1C=CC=CC=1C(C(=O)N(C)C)C1=CC=CC=C1 QAHFOPIILNICLA-UHFFFAOYSA-N 0.000 description 1
- YUBJPYNSGLJZPQ-UHFFFAOYSA-N Dithiopyr Chemical compound CSC(=O)C1=C(C(F)F)N=C(C(F)(F)F)C(C(=O)SC)=C1CC(C)C YUBJPYNSGLJZPQ-UHFFFAOYSA-N 0.000 description 1
- 239000005510 Diuron Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005767 Epoxiconazole Substances 0.000 description 1
- BXEHUCNTIZGSOJ-UHFFFAOYSA-N Esprocarb Chemical compound CC(C)C(C)N(CC)C(=O)SCC1=CC=CC=C1 BXEHUCNTIZGSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000005961 Ethoprophos Substances 0.000 description 1
- UWVKRNOCDUPIDM-UHFFFAOYSA-N Ethoxysulfuron Chemical compound CCOC1=CC=CC=C1OS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 UWVKRNOCDUPIDM-UHFFFAOYSA-N 0.000 description 1
- 239000005896 Etofenprox Substances 0.000 description 1
- 239000005897 Etoxazole Substances 0.000 description 1
- 239000005769 Etridiazole Substances 0.000 description 1
- FGIWFCGDPUIBEZ-UHFFFAOYSA-N Etrimfos Chemical compound CCOC1=CC(OP(=S)(OC)OC)=NC(CC)=N1 FGIWFCGDPUIBEZ-UHFFFAOYSA-N 0.000 description 1
- 239000005772 Famoxadone Substances 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005656 Fenazaquin Substances 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- NRFQZTCQAYEXEE-UHFFFAOYSA-N Fenclorim Chemical compound ClC1=CC(Cl)=NC(C=2C=CC=CC=2)=N1 NRFQZTCQAYEXEE-UHFFFAOYSA-N 0.000 description 1
- HMIBKHHNXANVHR-UHFFFAOYSA-N Fenothiocarb Chemical compound CN(C)C(=O)SCCCCOC1=CC=CC=C1 HMIBKHHNXANVHR-UHFFFAOYSA-N 0.000 description 1
- PQKBPHSEKWERTG-UHFFFAOYSA-N Fenoxaprop ethyl Chemical group C1=CC(OC(C)C(=O)OCC)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 PQKBPHSEKWERTG-UHFFFAOYSA-N 0.000 description 1
- 239000005898 Fenoxycarb Substances 0.000 description 1
- 239000005657 Fenpyroximate Substances 0.000 description 1
- PNVJTZOFSHSLTO-UHFFFAOYSA-N Fenthion Chemical compound COP(=S)(OC)OC1=CC=C(SC)C(C)=C1 PNVJTZOFSHSLTO-UHFFFAOYSA-N 0.000 description 1
- LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- 239000005900 Flonicamid Substances 0.000 description 1
- 239000005901 Flubendiamide Substances 0.000 description 1
- FICWGWVVIRLNRB-UHFFFAOYSA-N Flucetosulfuron Chemical compound COCC(=O)OC(C(C)F)C1=NC=CC=C1S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 FICWGWVVIRLNRB-UHFFFAOYSA-N 0.000 description 1
- 239000005531 Flufenacet Substances 0.000 description 1
- 239000005532 Flumioxazine Substances 0.000 description 1
- 239000005783 Fluopyram Substances 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- 239000005788 Fluxapyroxad Substances 0.000 description 1
- 239000005979 Forchlorfenuron Substances 0.000 description 1
- 239000005959 Fosthiazate Substances 0.000 description 1
- 239000005980 Gibberellic acid Substances 0.000 description 1
- 239000005564 Halosulfuron methyl Substances 0.000 description 1
- FMGZEUWROYGLAY-UHFFFAOYSA-N Halosulfuron-methyl Chemical group ClC1=NN(C)C(S(=O)(=O)NC(=O)NC=2N=C(OC)C=C(OC)N=2)=C1C(=O)OC FMGZEUWROYGLAY-UHFFFAOYSA-N 0.000 description 1
- CAWXEEYDBZRFPE-UHFFFAOYSA-N Hexazinone Chemical compound O=C1N(C)C(N(C)C)=NC(=O)N1C1CCCCC1 CAWXEEYDBZRFPE-UHFFFAOYSA-N 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- 239000005795 Imazalil Substances 0.000 description 1
- 239000005567 Imazosulfuron Substances 0.000 description 1
- NAGRVUXEKKZNHT-UHFFFAOYSA-N Imazosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N3C=CC=CC3=NC=2Cl)=N1 NAGRVUXEKKZNHT-UHFFFAOYSA-N 0.000 description 1
- PPCUNNLZTNMXFO-ACCUITESSA-N Imicyafos Chemical compound CCCSP(=O)(OCC)N1CCN(CC)\C1=N/C#N PPCUNNLZTNMXFO-ACCUITESSA-N 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- PFDCOZXELJAUTR-UHFFFAOYSA-N Inabenfide Chemical compound C=1C(Cl)=CC=C(NC(=O)C=2C=CN=CC=2)C=1C(O)C1=CC=CC=C1 PFDCOZXELJAUTR-UHFFFAOYSA-N 0.000 description 1
- PMAAYIYCDXGUAP-UHFFFAOYSA-N Indanofan Chemical compound O=C1C2=CC=CC=C2C(=O)C1(CC)CC1(C=2C=C(Cl)C=CC=2)CO1 PMAAYIYCDXGUAP-UHFFFAOYSA-N 0.000 description 1
- 239000005907 Indoxacarb Substances 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- 239000005797 Iprovalicarb Substances 0.000 description 1
- XRHGWAGWAHHFLF-UHFFFAOYSA-N Isazofos Chemical compound CCOP(=S)(OCC)OC=1N=C(Cl)N(C(C)C)N=1 XRHGWAGWAHHFLF-UHFFFAOYSA-N 0.000 description 1
- 239000005799 Isopyrazam Substances 0.000 description 1
- NWUWYYSKZYIQAE-ZBFHGGJFSA-N L-(R)-iprovalicarb Chemical compound CC(C)OC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C)C1=CC=C(C)C=C1 NWUWYYSKZYIQAE-ZBFHGGJFSA-N 0.000 description 1
- 239000005573 Linuron Substances 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- SUSRORUBZHMPCO-UHFFFAOYSA-N MC-4379 Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 SUSRORUBZHMPCO-UHFFFAOYSA-N 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 239000005804 Mandipropamid Substances 0.000 description 1
- 239000005805 Mepanipyrim Substances 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- RRVIAQKBTUQODI-UHFFFAOYSA-N Methabenzthiazuron Chemical compound C1=CC=C2SC(N(C)C(=O)NC)=NC2=C1 RRVIAQKBTUQODI-UHFFFAOYSA-N 0.000 description 1
- 239000005951 Methiocarb Substances 0.000 description 1
- 239000005916 Methomyl Substances 0.000 description 1
- 239000005917 Methoxyfenozide Substances 0.000 description 1
- 239000005581 Metobromuron Substances 0.000 description 1
- WLFDQEVORAMCIM-UHFFFAOYSA-N Metobromuron Chemical compound CON(C)C(=O)NC1=CC=C(Br)C=C1 WLFDQEVORAMCIM-UHFFFAOYSA-N 0.000 description 1
- 239000005810 Metrafenone Substances 0.000 description 1
- 239000005583 Metribuzin Substances 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- WXZVAROIGSFCFJ-UHFFFAOYSA-N N,N-diethyl-2-(naphthalen-1-yloxy)propanamide Chemical compound C1=CC=C2C(OC(C)C(=O)N(CC)CC)=CC=CC2=C1 WXZVAROIGSFCFJ-UHFFFAOYSA-N 0.000 description 1
- IUOKJNROJISWRO-UHFFFAOYSA-N N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide Chemical compound CC(C)C(C)(C#N)NC(=O)C(C)OC1=CC=C(Cl)C=C1Cl IUOKJNROJISWRO-UHFFFAOYSA-N 0.000 description 1
- NQRFDNJEBWAUBL-UHFFFAOYSA-N N-[cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide Chemical compound S1C(NCC)=NC(CC)=C1C(=O)NC(C#N)C1=CC=CS1 NQRFDNJEBWAUBL-UHFFFAOYSA-N 0.000 description 1
- NTBVTCXMRYKRTB-UHFFFAOYSA-N N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide Chemical compound COCC1=CC=CC(C(O)C=2N=C(OC)C=C(OC)N=2)=C1NS(=O)(=O)C(F)F NTBVTCXMRYKRTB-UHFFFAOYSA-N 0.000 description 1
- 239000005585 Napropamide Substances 0.000 description 1
- 239000005586 Nicosulfuron Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000005588 Oxadiazon Substances 0.000 description 1
- CHNUNORXWHYHNE-UHFFFAOYSA-N Oxadiazon Chemical compound C1=C(Cl)C(OC(C)C)=CC(N2C(OC(=N2)C(C)(C)C)=O)=C1Cl CHNUNORXWHYHNE-UHFFFAOYSA-N 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- FCOHEOSCARXMMS-UHFFFAOYSA-N Oxaziclomefone Chemical compound C1OC(C)=C(C=2C=CC=CC=2)C(=O)N1C(C)(C)C1=CC(Cl)=CC(Cl)=C1 FCOHEOSCARXMMS-UHFFFAOYSA-N 0.000 description 1
- 239000005590 Oxyfluorfen Substances 0.000 description 1
- OQMBBFQZGJFLBU-UHFFFAOYSA-N Oxyfluorfen Chemical compound C1=C([N+]([O-])=O)C(OCC)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 OQMBBFQZGJFLBU-UHFFFAOYSA-N 0.000 description 1
- 239000005985 Paclobutrazol Substances 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000005591 Pendimethalin Substances 0.000 description 1
- 239000005592 Penoxsulam Substances 0.000 description 1
- SYJGKVOENHZYMQ-UHFFFAOYSA-N Penoxsulam Chemical compound N1=C2C(OC)=CN=C(OC)N2N=C1NS(=O)(=O)C1=C(OCC(F)F)C=CC=C1C(F)(F)F SYJGKVOENHZYMQ-UHFFFAOYSA-N 0.000 description 1
- 239000005816 Penthiopyrad Substances 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- UNLYSVIDNRIVFJ-UHFFFAOYSA-N Piperophos Chemical compound CCCOP(=S)(OCCC)SCC(=O)N1CCCCC1C UNLYSVIDNRIVFJ-UHFFFAOYSA-N 0.000 description 1
- 239000005923 Pirimicarb Substances 0.000 description 1
- TZBPRYIIJAJUOY-UHFFFAOYSA-N Pirimiphos-ethyl Chemical group CCOP(=S)(OCC)OC1=CC(C)=NC(N(CC)CC)=N1 TZBPRYIIJAJUOY-UHFFFAOYSA-N 0.000 description 1
- 239000005924 Pirimiphos-methyl Substances 0.000 description 1
- YLPGTOIOYRQOHV-UHFFFAOYSA-N Pretilachlor Chemical compound CCCOCCN(C(=O)CCl)C1=C(CC)C=CC=C1CC YLPGTOIOYRQOHV-UHFFFAOYSA-N 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- DTAPQAJKAFRNJB-UHFFFAOYSA-N Promecarb Chemical compound CNC(=O)OC1=CC(C)=CC(C(C)C)=C1 DTAPQAJKAFRNJB-UHFFFAOYSA-N 0.000 description 1
- 239000005821 Propamocarb Substances 0.000 description 1
- 239000005600 Propaquizafop Substances 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 239000005602 Propyzamide Substances 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 239000005663 Pyridaben Substances 0.000 description 1
- 239000005926 Pyridalyl Substances 0.000 description 1
- RRKHIAYNPVQKEF-UHFFFAOYSA-N Pyriftalid Chemical compound COC1=CC(OC)=NC(SC=2C=3C(=O)OC(C)C=3C=CC=2)=N1 RRKHIAYNPVQKEF-UHFFFAOYSA-N 0.000 description 1
- 239000005927 Pyriproxyfen Substances 0.000 description 1
- 239000005608 Quinmerac Substances 0.000 description 1
- OBLNWSCLAYSJJR-UHFFFAOYSA-N Quinoclamin Chemical compound C1=CC=C2C(=O)C(N)=C(Cl)C(=O)C2=C1 OBLNWSCLAYSJJR-UHFFFAOYSA-N 0.000 description 1
- 239000002167 Quinoclamine Substances 0.000 description 1
- ISRUGXGCCGIOQO-UHFFFAOYSA-N Rhoden Chemical compound CNC(=O)OC1=CC=CC=C1OC(C)C ISRUGXGCCGIOQO-UHFFFAOYSA-N 0.000 description 1
- CSPPKDPQLUUTND-NBVRZTHBSA-N Sethoxydim Chemical compound CCO\N=C(/CCC)C1=C(O)CC(CC(C)SCC)CC1=O CSPPKDPQLUUTND-NBVRZTHBSA-N 0.000 description 1
- 239000005929 Spinetoram Substances 0.000 description 1
- GOENIMGKWNZVDA-OAMCMWGQSA-N Spinetoram Chemical compound CO[C@@H]1[C@H](OCC)[C@@H](OC)[C@H](C)O[C@H]1OC1C[C@H]2[C@@H]3C=C4C(=O)[C@H](C)[C@@H](O[C@@H]5O[C@H](C)[C@H](CC5)N(C)C)CCC[C@H](CC)OC(=O)CC4[C@@H]3CC[C@@H]2C1 GOENIMGKWNZVDA-OAMCMWGQSA-N 0.000 description 1
- 239000005664 Spirodiclofen Substances 0.000 description 1
- 239000005665 Spiromesifen Substances 0.000 description 1
- 239000005931 Spirotetramat Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000005934 Sulfoxaflor Substances 0.000 description 1
- 239000005937 Tebufenozide Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005938 Teflubenzuron Substances 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- KDWQYMVPYJGPHS-UHFFFAOYSA-N Thenylchlor Chemical compound C1=CSC(CN(C(=O)CCl)C=2C(=CC=CC=2C)C)=C1OC KDWQYMVPYJGPHS-UHFFFAOYSA-N 0.000 description 1
- 239000005940 Thiacloprid Substances 0.000 description 1
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 description 1
- QHTQREMOGMZHJV-UHFFFAOYSA-N Thiobencarb Chemical compound CCN(CC)C(=O)SCC1=CC=C(Cl)C=C1 QHTQREMOGMZHJV-UHFFFAOYSA-N 0.000 description 1
- 239000005845 Tolclofos-methyl Substances 0.000 description 1
- 239000005625 Tri-allate Substances 0.000 description 1
- MWBPRDONLNQCFV-UHFFFAOYSA-N Tri-allate Chemical compound CC(C)N(C(C)C)C(=O)SCC(Cl)=C(Cl)Cl MWBPRDONLNQCFV-UHFFFAOYSA-N 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 239000005942 Triflumuron Substances 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 239000005863 Zoxamide Substances 0.000 description 1
- BZMIHNKNQJJVRO-LVZFUZTISA-N [(e)-c-(3-chloro-2,6-dimethoxyphenyl)-n-ethoxycarbonimidoyl] benzoate Chemical compound COC=1C=CC(Cl)=C(OC)C=1C(=N/OCC)\OC(=O)C1=CC=CC=C1 BZMIHNKNQJJVRO-LVZFUZTISA-N 0.000 description 1
- FSAVDKDHPDSCTO-WQLSENKSSA-N [(z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate Chemical compound CCOP(=O)(OCC)O\C(=C/Cl)C1=CC=C(Cl)C=C1Cl FSAVDKDHPDSCTO-WQLSENKSSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- YLFSVIMMRPNPFK-WEQBUNFVSA-N acrinathrin Chemical compound CC1(C)[C@@H](\C=C/C(=O)OC(C(F)(F)F)C(F)(F)F)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YLFSVIMMRPNPFK-WEQBUNFVSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- XCSGPAVHZFQHGE-UHFFFAOYSA-N alachlor Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl XCSGPAVHZFQHGE-UHFFFAOYSA-N 0.000 description 1
- GGKQIOFASHYUJZ-UHFFFAOYSA-N ametoctradin Chemical compound NC1=C(CCCCCCCC)C(CC)=NC2=NC=NN21 GGKQIOFASHYUJZ-UHFFFAOYSA-N 0.000 description 1
- BREATYVWRHIPIY-UHFFFAOYSA-N amisulbrom Chemical compound CN(C)S(=O)(=O)N1C=NC(S(=O)(=O)N2C3=CC(F)=CC=C3C(Br)=C2C)=N1 BREATYVWRHIPIY-UHFFFAOYSA-N 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- AKNQMEBLVAMSNZ-UHFFFAOYSA-N azaconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCCO1 AKNQMEBLVAMSNZ-UHFFFAOYSA-N 0.000 description 1
- 229950000294 azaconazole Drugs 0.000 description 1
- MAHPNPYYQAIOJN-UHFFFAOYSA-N azimsulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N(N=CC=2C2=NN(C)N=N2)C)=N1 MAHPNPYYQAIOJN-UHFFFAOYSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical group COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
- USRKFGIXLGKMKU-ABAIWWIYSA-N benthiavalicarb-isopropyl Chemical compound C1=C(F)C=C2SC([C@@H](C)NC(=O)[C@H](C(C)C)NC(=O)OC(C)C)=NC2=C1 USRKFGIXLGKMKU-ABAIWWIYSA-N 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- WZDDLAZXUYIVMU-UHFFFAOYSA-N bromobutide Chemical compound CC(C)(C)C(Br)C(=O)NC(C)(C)C1=CC=CC=C1 WZDDLAZXUYIVMU-UHFFFAOYSA-N 0.000 description 1
- FOANIXZHAMJWOI-UHFFFAOYSA-N bromopropylate Chemical compound C=1C=C(Br)C=CC=1C(O)(C(=O)OC(C)C)C1=CC=C(Br)C=C1 FOANIXZHAMJWOI-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- HKPHPIREJKHECO-UHFFFAOYSA-N butachlor Chemical compound CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC HKPHPIREJKHECO-UHFFFAOYSA-N 0.000 description 1
- JEDYYFXHPAIBGR-UHFFFAOYSA-N butafenacil Chemical compound O=C1N(C)C(C(F)(F)F)=CC(=O)N1C1=CC=C(Cl)C(C(=O)OC(C)(C)C(=O)OCC=C)=C1 JEDYYFXHPAIBGR-UHFFFAOYSA-N 0.000 description 1
- HFEJHAAIJZXXRE-UHFFFAOYSA-N cafenstrole Chemical compound CCN(CC)C(=O)N1C=NC(S(=O)(=O)C=2C(=CC(C)=CC=2C)C)=N1 HFEJHAAIJZXXRE-UHFFFAOYSA-N 0.000 description 1
- 229960005286 carbaryl Drugs 0.000 description 1
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 1
- GYSSRZJIHXQEHQ-UHFFFAOYSA-N carboxin Chemical compound S1CCOC(C)=C1C(=O)NC1=CC=CC=C1 GYSSRZJIHXQEHQ-UHFFFAOYSA-N 0.000 description 1
- RXDMAYSSBPYBFW-PKFCDNJMSA-N carpropamide Chemical compound N([C@@H](C)C=1C=CC(Cl)=CC=1)C(=O)[C@@]1(CC)[C@H](C)C1(Cl)Cl RXDMAYSSBPYBFW-PKFCDNJMSA-N 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- BIWJNBZANLAXMG-YQELWRJZSA-N chloordaan Chemical compound ClC1=C(Cl)[C@@]2(Cl)C3CC(Cl)C(Cl)C3[C@]1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-YQELWRJZSA-N 0.000 description 1
- PSOVNZZNOMJUBI-UHFFFAOYSA-N chlorantraniliprole Chemical compound CNC(=O)C1=CC(Cl)=CC(C)=C1NC(=O)C1=CC(Br)=NN1C1=NC=CC=C1Cl PSOVNZZNOMJUBI-UHFFFAOYSA-N 0.000 description 1
- CWFOCCVIPCEQCK-UHFFFAOYSA-N chlorfenapyr Chemical compound BrC1=C(C(F)(F)F)N(COCC)C(C=2C=CC(Cl)=CC=2)=C1C#N CWFOCCVIPCEQCK-UHFFFAOYSA-N 0.000 description 1
- UISUNVFOGSJSKD-UHFFFAOYSA-N chlorfluazuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC(C=C1Cl)=CC(Cl)=C1OC1=NC=C(C(F)(F)F)C=C1Cl UISUNVFOGSJSKD-UHFFFAOYSA-N 0.000 description 1
- CWJSHJJYOPWUGX-UHFFFAOYSA-N chlorpropham Chemical compound CC(C)OC(=O)NC1=CC=CC(Cl)=C1 CWJSHJJYOPWUGX-UHFFFAOYSA-N 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
- SILSDTWXNBZOGF-JWGBMQLESA-N clethodim Chemical compound CCSC(C)CC1CC(O)=C(C(CC)=NOC\C=C\Cl)C(=O)C1 SILSDTWXNBZOGF-JWGBMQLESA-N 0.000 description 1
- UXADOQPNKNTIHB-UHFFFAOYSA-N clofentezine Chemical compound ClC1=CC=CC=C1C1=NN=C(C=2C(=CC=CC=2)Cl)N=N1 UXADOQPNKNTIHB-UHFFFAOYSA-N 0.000 description 1
- KIEDNEWSYUYDSN-UHFFFAOYSA-N clomazone Chemical compound O=C1C(C)(C)CON1CC1=CC=CC=C1Cl KIEDNEWSYUYDSN-UHFFFAOYSA-N 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- YXKMMRDKEKCERS-UHFFFAOYSA-N cyazofamid Chemical compound CN(C)S(=O)(=O)N1C(C#N)=NC(Cl)=C1C1=CC=C(C)C=C1 YXKMMRDKEKCERS-UHFFFAOYSA-N 0.000 description 1
- ACMXQHFNODYQAT-UHFFFAOYSA-N cyflufenamid Chemical compound FC1=CC=C(C(F)(F)F)C(C(NOCC2CC2)=NC(=O)CC=2C=CC=CC=2)=C1F ACMXQHFNODYQAT-UHFFFAOYSA-N 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- HAORKNGNJCEJBX-UHFFFAOYSA-N cyprodinil Chemical compound N=1C(C)=CC(C2CC2)=NC=1NC1=CC=CC=C1 HAORKNGNJCEJBX-UHFFFAOYSA-N 0.000 description 1
- WEBQKRLKWNIYKK-UHFFFAOYSA-N demeton-S-methyl Chemical compound CCSCCSP(=O)(OC)OC WEBQKRLKWNIYKK-UHFFFAOYSA-N 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- OEBRKCOSUFCWJD-UHFFFAOYSA-N dichlorvos Chemical compound COP(=O)(OC)OC=C(Cl)Cl OEBRKCOSUFCWJD-UHFFFAOYSA-N 0.000 description 1
- 229940004812 dicloran Drugs 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 description 1
- 229950006824 dieldrin Drugs 0.000 description 1
- NGPMUTDCEIKKFM-UHFFFAOYSA-N dieldrin Natural products CC1=C(Cl)C2(Cl)C3C4CC(C5OC45)C3C1(Cl)C2(Cl)Cl NGPMUTDCEIKKFM-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- QQQYTWIFVNKMRW-UHFFFAOYSA-N diflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC=C(Cl)C=C1 QQQYTWIFVNKMRW-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- BWUPSGJXXPATLU-UHFFFAOYSA-N dimepiperate Chemical compound C=1C=CC=CC=1C(C)(C)SC(=O)N1CCCCC1 BWUPSGJXXPATLU-UHFFFAOYSA-N 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 1
- YKBZOVFACRVRJN-UHFFFAOYSA-N dinotefuran Chemical compound [O-][N+](=O)\N=C(/NC)NCC1CCOC1 YKBZOVFACRVRJN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DOFZAZXDOSGAJZ-UHFFFAOYSA-N disulfoton Chemical compound CCOP(=S)(OCC)SCCSCC DOFZAZXDOSGAJZ-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- RDYMFSUJUZBWLH-SVWSLYAFSA-N endosulfan Chemical compound C([C@@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-SVWSLYAFSA-N 0.000 description 1
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 description 1
- 229960002125 enilconazole Drugs 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- HEZNVIYQEUHLNI-UHFFFAOYSA-N ethiofencarb Chemical compound CCSCC1=CC=CC=C1OC(=O)NC HEZNVIYQEUHLNI-UHFFFAOYSA-N 0.000 description 1
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 description 1
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 description 1
- MLKCGVHIFJBRCD-UHFFFAOYSA-N ethyl 2-chloro-3-{2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluorophenyl}propanoate Chemical group C1=C(Cl)C(CC(Cl)C(=O)OCC)=CC(N2C(N(C(F)F)C(C)=N2)=O)=C1F MLKCGVHIFJBRCD-UHFFFAOYSA-N 0.000 description 1
- OSUHJPCHFDQAIT-UHFFFAOYSA-N ethyl 2-{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy}propanoate Chemical group C1=CC(OC(C)C(=O)OCC)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 OSUHJPCHFDQAIT-UHFFFAOYSA-N 0.000 description 1
- YREQHYQNNWYQCJ-UHFFFAOYSA-N etofenprox Chemical compound C1=CC(OCC)=CC=C1C(C)(C)COCC1=CC=CC(OC=2C=CC=CC=2)=C1 YREQHYQNNWYQCJ-UHFFFAOYSA-N 0.000 description 1
- 229950005085 etofenprox Drugs 0.000 description 1
- IXSZQYVWNJNRAL-UHFFFAOYSA-N etoxazole Chemical compound CCOC1=CC(C(C)(C)C)=CC=C1C1N=C(C=2C(=CC=CC=2F)F)OC1 IXSZQYVWNJNRAL-UHFFFAOYSA-N 0.000 description 1
- KQTVWCSONPJJPE-UHFFFAOYSA-N etridiazole Chemical compound CCOC1=NC(C(Cl)(Cl)Cl)=NS1 KQTVWCSONPJJPE-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- DMYHGDXADUDKCQ-UHFFFAOYSA-N fenazaquin Chemical compound C1=CC(C(C)(C)C)=CC=C1CCOC1=NC=NC2=CC=CC=C12 DMYHGDXADUDKCQ-UHFFFAOYSA-N 0.000 description 1
- ZNOLGFHPUIJIMJ-UHFFFAOYSA-N fenitrothion Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C(C)=C1 ZNOLGFHPUIJIMJ-UHFFFAOYSA-N 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- GOWLARCWZRESHU-AQTBWJFISA-N ferimzone Chemical compound C=1C=CC=C(C)C=1C(/C)=N\NC1=NC(C)=CC(C)=N1 GOWLARCWZRESHU-AQTBWJFISA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- RLQJEEJISHYWON-UHFFFAOYSA-N flonicamid Chemical compound FC(F)(F)C1=CC=NC=C1C(=O)NCC#N RLQJEEJISHYWON-UHFFFAOYSA-N 0.000 description 1
- MXWAGQASUDSFBG-RVDMUPIBSA-N fluacrypyrim Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC(C(F)(F)F)=NC(OC(C)C)=N1 MXWAGQASUDSFBG-RVDMUPIBSA-N 0.000 description 1
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 1
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 description 1
- IANUJLZYFUDJIH-UHFFFAOYSA-N flufenacet Chemical compound C=1C=C(F)C=CC=1N(C(C)C)C(=O)COC1=NN=C(C(F)(F)F)S1 IANUJLZYFUDJIH-UHFFFAOYSA-N 0.000 description 1
- RYLHNOVXKPXDIP-UHFFFAOYSA-N flufenoxuron Chemical compound C=1C=C(NC(=O)NC(=O)C=2C(=CC=CC=2F)F)C(F)=CC=1OC1=CC=C(C(F)(F)F)C=C1Cl RYLHNOVXKPXDIP-UHFFFAOYSA-N 0.000 description 1
- FOUWCSDKDDHKQP-UHFFFAOYSA-N flumioxazin Chemical compound FC1=CC=2OCC(=O)N(CC#C)C=2C=C1N(C1=O)C(=O)C2=C1CCCC2 FOUWCSDKDDHKQP-UHFFFAOYSA-N 0.000 description 1
- KVDJTXBXMWJJEF-UHFFFAOYSA-N fluopyram Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CCNC(=O)C1=CC=CC=C1C(F)(F)F KVDJTXBXMWJJEF-UHFFFAOYSA-N 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- SXSGXWCSHSVPGB-UHFFFAOYSA-N fluxapyroxad Chemical compound FC(F)C1=NN(C)C=C1C(=O)NC1=CC=CC=C1C1=CC(F)=C(F)C(F)=C1 SXSGXWCSHSVPGB-UHFFFAOYSA-N 0.000 description 1
- KVGLBTYUCJYMND-UHFFFAOYSA-N fonofos Chemical compound CCOP(=S)(CC)SC1=CC=CC=C1 KVGLBTYUCJYMND-UHFFFAOYSA-N 0.000 description 1
- GPXLRLUVLMHHIK-UHFFFAOYSA-N forchlorfenuron Chemical compound C1=NC(Cl)=CC(NC(=O)NC=2C=CC=CC=2)=C1 GPXLRLUVLMHHIK-UHFFFAOYSA-N 0.000 description 1
- DUFVKSUJRWYZQP-UHFFFAOYSA-N fosthiazate Chemical compound CCC(C)SP(=O)(OCC)N1CCSC1=O DUFVKSUJRWYZQP-UHFFFAOYSA-N 0.000 description 1
- HAWJXYBZNNRMNO-UHFFFAOYSA-N furathiocarb Chemical compound CCCCOC(=O)N(C)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2 HAWJXYBZNNRMNO-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- WIFXJBMOTMKRMM-UHFFFAOYSA-N halfenprox Chemical compound C=1C=C(OC(F)(F)Br)C=CC=1C(C)(C)COCC(C=1)=CC=CC=1OC1=CC=CC=C1 WIFXJBMOTMKRMM-UHFFFAOYSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- FRCCEHPWNOQAEU-UHFFFAOYSA-N heptachlor Chemical compound ClC1=C(Cl)C2(Cl)C3C=CC(Cl)C3C1(Cl)C2(Cl)Cl FRCCEHPWNOQAEU-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- RGNPBRKPHBKNKX-UHFFFAOYSA-N hexaflumuron Chemical compound C1=C(Cl)C(OC(F)(F)C(F)F)=C(Cl)C=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F RGNPBRKPHBKNKX-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- AGKSTYPVMZODRV-UHFFFAOYSA-N imibenconazole Chemical compound C1=CC(Cl)=CC=C1CSC(CN1N=CN=C1)=NC1=CC=C(Cl)C=C1Cl AGKSTYPVMZODRV-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- QBSJMKIUCUGGNG-UHFFFAOYSA-N isoprocarb Chemical compound CNC(=O)OC1=CC=CC=C1C(C)C QBSJMKIUCUGGNG-UHFFFAOYSA-N 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- 229960002809 lindane Drugs 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- KLGMSAOQDHLCOS-UHFFFAOYSA-N mecarbam Chemical compound CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC KLGMSAOQDHLCOS-UHFFFAOYSA-N 0.000 description 1
- XIGAUIHYSDTJHW-UHFFFAOYSA-N mefenacet Chemical compound N=1C2=CC=CC=C2SC=1OCC(=O)N(C)C1=CC=CC=C1 XIGAUIHYSDTJHW-UHFFFAOYSA-N 0.000 description 1
- CIFWZNRJIBNXRE-UHFFFAOYSA-N mepanipyrim Chemical compound CC#CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 CIFWZNRJIBNXRE-UHFFFAOYSA-N 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- YFBPRJGDJKVWAH-UHFFFAOYSA-N methiocarb Chemical compound CNC(=O)OC1=CC(C)=C(SC)C(C)=C1 YFBPRJGDJKVWAH-UHFFFAOYSA-N 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- QCAWEPFNJXQPAN-UHFFFAOYSA-N methoxyfenozide Chemical compound COC1=CC=CC(C(=O)NN(C(=O)C=2C=C(C)C=C(C)C=2)C(C)(C)C)=C1C QCAWEPFNJXQPAN-UHFFFAOYSA-N 0.000 description 1
- GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
- BACHBFVBHLGWSL-UHFFFAOYSA-N methyl 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate Chemical group C1=CC(OC(C)C(=O)OC)=CC=C1OC1=CC=C(Cl)C=C1Cl BACHBFVBHLGWSL-UHFFFAOYSA-N 0.000 description 1
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 1
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 description 1
- FOXFZRUHNHCZPX-UHFFFAOYSA-N metribuzin Chemical compound CSC1=NN=C(C(C)(C)C)C(=O)N1N FOXFZRUHNHCZPX-UHFFFAOYSA-N 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical compound O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- RTCOGUMHFFWOJV-UHFFFAOYSA-N nicosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CN=2)C(=O)N(C)C)=N1 RTCOGUMHFFWOJV-UHFFFAOYSA-N 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- PZXOQEXFMJCDPG-UHFFFAOYSA-N omethoate Chemical compound CNC(=O)CSP(=O)(OC)OC PZXOQEXFMJCDPG-UHFFFAOYSA-N 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical group CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- CHIFOSRWCNZCFN-UHFFFAOYSA-N pendimethalin Chemical compound CCC(CC)NC1=C([N+]([O-])=O)C=C(C)C(C)=C1[N+]([O-])=O CHIFOSRWCNZCFN-UHFFFAOYSA-N 0.000 description 1
- LKPLKUMXSAEKID-UHFFFAOYSA-N pentachloronitrobenzene Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LKPLKUMXSAEKID-UHFFFAOYSA-N 0.000 description 1
- JZPKLLLUDLHCEL-UHFFFAOYSA-N pentoxazone Chemical compound O=C1C(=C(C)C)OC(=O)N1C1=CC(OC2CCCC2)=C(Cl)C=C1F JZPKLLLUDLHCEL-UHFFFAOYSA-N 0.000 description 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- ATROHALUCMTWTB-OWBHPGMISA-N phoxim Chemical compound CCOP(=S)(OCC)O\N=C(\C#N)C1=CC=CC=C1 ATROHALUCMTWTB-OWBHPGMISA-N 0.000 description 1
- 229950001664 phoxim Drugs 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 1
- QHOQHJPRIBSPCY-UHFFFAOYSA-N pirimiphos-methyl Chemical group CCN(CC)C1=NC(C)=CC(OP(=S)(OC)OC)=N1 QHOQHJPRIBSPCY-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- MFOUDYKPLGXPGO-UHFFFAOYSA-N propachlor Chemical compound ClCC(=O)N(C(C)C)C1=CC=CC=C1 MFOUDYKPLGXPGO-UHFFFAOYSA-N 0.000 description 1
- WZZLDXDUQPOXNW-UHFFFAOYSA-N propamocarb Chemical compound CCCOC(=O)NCCCN(C)C WZZLDXDUQPOXNW-UHFFFAOYSA-N 0.000 description 1
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 description 1
- FROBCXTULYFHEJ-OAHLLOKOSA-N propaquizafop Chemical compound C1=CC(O[C@H](C)C(=O)OCCON=C(C)C)=CC=C1OC1=CN=C(C=C(Cl)C=C2)C2=N1 FROBCXTULYFHEJ-OAHLLOKOSA-N 0.000 description 1
- WJNRPILHGGKWCK-UHFFFAOYSA-N propazine Chemical compound CC(C)NC1=NC(Cl)=NC(NC(C)C)=N1 WJNRPILHGGKWCK-UHFFFAOYSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- PHNUZKMIPFFYSO-UHFFFAOYSA-N propyzamide Chemical compound C#CC(C)(C)NC(=O)C1=CC(Cl)=CC(Cl)=C1 PHNUZKMIPFFYSO-UHFFFAOYSA-N 0.000 description 1
- FITIWKDOCAUBQD-UHFFFAOYSA-N prothiofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(Cl)C=C1Cl FITIWKDOCAUBQD-UHFFFAOYSA-N 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- ASRAWSBMDXVNLX-UHFFFAOYSA-N pyrazolynate Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)C=1C(C)=NN(C)C=1OS(=O)(=O)C1=CC=C(C)C=C1 ASRAWSBMDXVNLX-UHFFFAOYSA-N 0.000 description 1
- JOOMJVFZQRQWKR-UHFFFAOYSA-N pyrazophos Chemical compound N1=C(C)C(C(=O)OCC)=CN2N=C(OP(=S)(OCC)OCC)C=C21 JOOMJVFZQRQWKR-UHFFFAOYSA-N 0.000 description 1
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 description 1
- DWFZBUWUXWZWKD-UHFFFAOYSA-N pyridaben Chemical compound C1=CC(C(C)(C)C)=CC=C1CSC1=C(Cl)C(=O)N(C(C)(C)C)N=C1 DWFZBUWUXWZWKD-UHFFFAOYSA-N 0.000 description 1
- AEHJMNVBLRLZKK-UHFFFAOYSA-N pyridalyl Chemical group N1=CC(C(F)(F)F)=CC=C1OCCCOC1=C(Cl)C=C(OCC=C(Cl)Cl)C=C1Cl AEHJMNVBLRLZKK-UHFFFAOYSA-N 0.000 description 1
- CXJSOEPQXUCJSA-UHFFFAOYSA-N pyridaphenthion Chemical compound N1=C(OP(=S)(OCC)OCC)C=CC(=O)N1C1=CC=CC=C1 CXJSOEPQXUCJSA-UHFFFAOYSA-N 0.000 description 1
- MIOBBYRMXGNORL-UHFFFAOYSA-N pyrifluquinazon Chemical compound C1C2=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C2N(C(=O)C)C(=O)N1NCC1=CC=CN=C1 MIOBBYRMXGNORL-UHFFFAOYSA-N 0.000 description 1
- ITKAIUGKVKDENI-UHFFFAOYSA-N pyrimidifen Chemical compound CC1=C(C)C(CCOCC)=CC=C1OCCNC1=NC=NC(CC)=C1Cl ITKAIUGKVKDENI-UHFFFAOYSA-N 0.000 description 1
- USSIUIGPBLPCDF-KEBDBYFISA-N pyriminobac-methyl Chemical group CO\N=C(/C)C1=CC=CC(OC=2N=C(OC)C=C(OC)N=2)=C1C(=O)OC USSIUIGPBLPCDF-KEBDBYFISA-N 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- JYQUHIFYBATCCY-UHFFFAOYSA-N quinalphos Chemical compound C1=CC=CC2=NC(OP(=S)(OCC)OCC)=CN=C21 JYQUHIFYBATCCY-UHFFFAOYSA-N 0.000 description 1
- ALZOLUNSQWINIR-UHFFFAOYSA-N quinmerac Chemical compound OC(=O)C1=C(Cl)C=CC2=CC(C)=CN=C21 ALZOLUNSQWINIR-UHFFFAOYSA-N 0.000 description 1
- BACHBFVBHLGWSL-JTQLQIEISA-N rac-diclofop methyl Natural products C1=CC(O[C@@H](C)C(=O)OC)=CC=C1OC1=CC=C(Cl)C=C1Cl BACHBFVBHLGWSL-JTQLQIEISA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- GNHDVXLWBQYPJE-UHFFFAOYSA-N saflufenacil Chemical compound C1=C(Cl)C(C(=O)NS(=O)(=O)N(C)C(C)C)=CC(N2C(N(C)C(=CC2=O)C(F)(F)F)=O)=C1F GNHDVXLWBQYPJE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HPYNBECUCCGGPA-UHFFFAOYSA-N silafluofen Chemical compound C1=CC(OCC)=CC=C1[Si](C)(C)CCCC1=CC=C(F)C(OC=2C=CC=CC=2)=C1 HPYNBECUCCGGPA-UHFFFAOYSA-N 0.000 description 1
- ODCWYMIRDDJXKW-UHFFFAOYSA-N simazine Chemical compound CCNC1=NC(Cl)=NC(NCC)=N1 ODCWYMIRDDJXKW-UHFFFAOYSA-N 0.000 description 1
- MGLWZSOBALDPEK-UHFFFAOYSA-N simetryn Chemical compound CCNC1=NC(NCC)=NC(SC)=N1 MGLWZSOBALDPEK-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- DTDSAWVUFPGDMX-UHFFFAOYSA-N spirodiclofen Chemical compound CCC(C)(C)C(=O)OC1=C(C=2C(=CC(Cl)=CC=2)Cl)C(=O)OC11CCCCC1 DTDSAWVUFPGDMX-UHFFFAOYSA-N 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- CLSVJBIHYWPGQY-GGYDESQDSA-N spirotetramat Chemical compound CCOC(=O)OC1=C(C=2C(=CC=C(C)C=2)C)C(=O)N[C@@]11CC[C@H](OC)CC1 CLSVJBIHYWPGQY-GGYDESQDSA-N 0.000 description 1
- QYPNKSZPJQQLRK-UHFFFAOYSA-N tebufenozide Chemical compound C1=CC(CC)=CC=C1C(=O)NN(C(C)(C)C)C(=O)C1=CC(C)=CC(C)=C1 QYPNKSZPJQQLRK-UHFFFAOYSA-N 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- CJDWRQLODFKPEL-UHFFFAOYSA-N teflubenzuron Chemical compound FC1=CC=CC(F)=C1C(=O)NC(=O)NC1=CC(Cl)=C(F)C(Cl)=C1F CJDWRQLODFKPEL-UHFFFAOYSA-N 0.000 description 1
- IROINLKCQGIITA-UHFFFAOYSA-N terbutryn Chemical compound CCNC1=NC(NC(C)(C)C)=NC(SC)=N1 IROINLKCQGIITA-UHFFFAOYSA-N 0.000 description 1
- FZXISNSWEXTPMF-UHFFFAOYSA-N terbutylazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)(C)C)=N1 FZXISNSWEXTPMF-UHFFFAOYSA-N 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- MLGCXEBRWGEOQX-UHFFFAOYSA-N tetradifon Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)C1=CC(Cl)=C(Cl)C=C1Cl MLGCXEBRWGEOQX-UHFFFAOYSA-N 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- WOSNCVAPUOFXEH-UHFFFAOYSA-N thifluzamide Chemical compound S1C(C)=NC(C(F)(F)F)=C1C(=O)NC1=C(Br)C=C(OC(F)(F)F)C=C1Br WOSNCVAPUOFXEH-UHFFFAOYSA-N 0.000 description 1
- VJQYLJSMBWXGDV-UHFFFAOYSA-N tiadinil Chemical compound N1=NSC(C(=O)NC=2C=C(Cl)C(C)=CC=2)=C1C VJQYLJSMBWXGDV-UHFFFAOYSA-N 0.000 description 1
- OBZIQQJJIKNWNO-UHFFFAOYSA-N tolclofos-methyl Chemical compound COP(=S)(OC)OC1=C(Cl)C=C(C)C=C1Cl OBZIQQJJIKNWNO-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- ZXFXBSWRVIQKOD-UHFFFAOYSA-N trans-heptachlor epoxide Natural products ClC1=C(Cl)C2(Cl)C3C4OC4C(Cl)C3C1(Cl)C2(Cl)Cl ZXFXBSWRVIQKOD-UHFFFAOYSA-N 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 1
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
- LESVOLZBIFDZGS-UHFFFAOYSA-N vamidothion Chemical compound CNC(=O)C(C)SCCSP(=O)(OC)OC LESVOLZBIFDZGS-UHFFFAOYSA-N 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/23—Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
본 발명은 (1) 인삼에 물 및 글리세린지방산에스테르를 투입한 후 추출하여 인삼 추출액을 제조하는 단계; (2) 상기 (1)단계의 제조한 인삼 추출액에 식용유를 첨가한 후 교반하는 단계; (3) 상기 (2)단계의 교반한 인삼 오일액을 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거하는 단계; (4) 상기 (3)단계의 오일층을 제거한 인삼 추출액층을 한외여과하는 단계; 및 (5) 상기 (4)단계의 한외여과한 인삼 추출액을 농축하는 단계를 포함하여 제조하는 것을 특징으로 하는 농약 함량이 저감된 인삼 농축액의 제조방법 및 상기 방법으로 제조된 농약 함량이 저감된 인삼 농축액에 관한 것이다.The present invention comprises the steps of (1) preparing a ginseng extract by adding water and glycerin fatty acid ester to ginseng and then extracting; (2) stirring after adding edible oil to the ginseng extract prepared in step (1); (3) removing the upper oil layer from the ginseng oil liquid separated into an upper oil layer and a lower ginseng extract layer by allowing the stirred ginseng oil liquid of step (2) to stand; (4) ultra-filtering the ginseng extract layer from which the oil layer of step (3) has been removed; and (5) a method for producing a ginseng concentrate with reduced pesticide content, characterized in that it comprises the step of concentrating the ultra-filtered ginseng extract of step (4), and ginseng with reduced pesticide content prepared by the method It's about the concentrate.
농약이란 농작물 재배를 위해 농경지의 토양 및 종자를 소독하거나, 작물 재배기간 중에 발생하는 병해충으로부터 농작물을 보호하고, 저장 농산물의 병해충을 방제하기 위한 목적으로 사용하는 모든 약제를 말한다.Pesticides refer to all drugs used for the purpose of disinfecting the soil and seeds of farmland for growing crops, protecting crops from pests and pests occurring during crop cultivation, and controlling diseases and pests of stored agricultural products.
종류에 따라 다소간 차이는 있으나 어느 정도의 독성이 있어서, 농약을 과다하게 사용하면 농작물에 약해를 일으키거나 농산물 중에 과량의 농약이 잔류하여 우리의 먹을거리를 오염시키고, 환경을 오염시키는 등의 부작용을 일으킬 가능성이 있다.Although there are some differences depending on the type, there is a certain degree of toxicity, so excessive use of pesticides may cause adverse effects such as damage to crops or excessive pesticide residues in agricultural products, contaminating our food and polluting the environment. is likely to cause
특히, 식품의약안전처는 농산물을 식품으로 간주하여 농산물의 농약잔류 허용기준을 설정하고 있으며, 이를 초과하는 농산물의 경우에는 시장에 출하할 수 없도록 하고 있다.In particular, the Ministry of Food and Drug Safety considers agricultural products as food and sets acceptable standards for pesticide residues in agricultural products.
인삼은 한국의 대표적인 경제작물 중의 하나로 4~6년 동안 같은 장소에서 재배되므로 병충해 방지를 위하여 부득이 하게 농약을 사용하고 있다. 경작에 필요한 농약의 종류는 정부가 정하고 있으며 잔류 허용기준을 설정하여 안전한 제품이 유통될 수 있도록 관리되고 있다.Ginseng is one of Korea's representative economic crops and is grown in the same place for 4 to 6 years, so pesticides are inevitably used to prevent pests and diseases. The types of pesticides required for cultivation are set by the government, and residue tolerance standards are set so that safe products can be distributed.
하지만 잔류 농약과 환경 오염물로부터 안전하고자 하는 소비자들의 유기농 제품에 대한 선호도가 높아가고 있으나, 유기농 인삼의 유통량은 대단히 적으며 가격이 너무 높다. 또한 잔류 농약 허용기준이 국가별로 차이가 있으며, 미국, 일본 등은 우리나라 허용기준보다 낮은 수치로 관리되고 있어 수출하고자 할때 대단히 큰 장애물로 대두되어 있다.However, consumers who want to be safe from pesticide residues and environmental pollutants have a growing preference for organic products, but the distribution of organic ginseng is very small and the price is too high. In addition, there are differences in the permissible standards for pesticide residues by country, and the United States and Japan are managed at a lower level than Korea's permissible standards, which is a very big obstacle when trying to export.
한국등록특허 제1210522호에는 인삼의 잔류농약 제거방법이 개시되어 있고, 한국등록특허 제1638544호에는 식물 분말의 잔류농약 제거방법이 개시되어 있으나, 본 발명의 3단계 처리에 의한 천연식물 추출물 내 잔류농약 제거방법과는 상이하다.Korean Patent No. 1210522 discloses a method for removing pesticide residues in ginseng, and Korean Patent Registration No. 1638544 discloses a method for removing pesticide residues from plant powder, but residues in natural plant extracts by the three-step treatment of the present invention It is different from the method of removing pesticides.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명의 목적은 인삼 농축액의 품질은 최대한 유지하면서 인삼 농축액 내 잔류농약 함량을 효과적으로 저감시킬 수 있는 인삼 농축액을 제조하기 위해, 처리 공정을 최적화하여, 프탈레이트 및 잔류농약과 같은 유해성분 감소를 극대화한 인삼 농축액의 제조방법을 제공하는 데 있다.The present invention has been derived from the above needs, and an object of the present invention is to optimize the treatment process to produce a ginseng concentrate that can effectively reduce the residual pesticide content in the ginseng concentrate while maintaining the quality of the ginseng concentrate as much as possible. , to provide a method for producing a ginseng concentrate that maximizes the reduction of harmful components such as phthalates and residual pesticides.
상기 과제를 해결하기 위해, 본 발명은 (1) 인삼에 물 및 글리세린지방산에스테르를 투입한 후 추출하여 인삼 추출액을 제조하는 단계; (2) 상기 (1)단계의 제조한 인삼 추출액에 식용유를 첨가한 후 교반하는 단계; (3) 상기 (2)단계의 교반한 인삼 오일액을 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거하는 단계; (4) 상기 (3)단계의 오일층을 제거한 인삼 추출액층을 한외여과하는 단계; 및 (5) 상기 (4)단계의 한외여과한 인삼 추출액을 농축하는 단계를 포함하여 제조하는 것을 특징으로 하는 농약 함량이 저감된 인삼 농축액의 제조방법을 제공한다.In order to solve the above problems, the present invention comprises the steps of (1) preparing a ginseng extract by adding water and glycerin fatty acid ester to ginseng and then extracting; (2) stirring after adding edible oil to the ginseng extract prepared in step (1); (3) removing the upper oil layer from the ginseng oil liquid separated into an upper oil layer and a lower ginseng extract layer by allowing the stirred ginseng oil liquid of step (2) to stand; (4) ultra-filtering the ginseng extract layer from which the oil layer of step (3) has been removed; And (5) provides a method for producing a ginseng concentrate with reduced pesticide content, characterized in that it comprises the step of concentrating the ultra-filtered ginseng extract of the step (4).
또한, 본 발명은 상기 방법으로 제조된 농약 함량이 저감된 인삼 농축액을 제공한다.In addition, the present invention provides a ginseng concentrate with reduced pesticide content prepared by the above method.
본 발명의 방법으로 가공처리된 인삼 농축액은 320종의 농약성분은 완전히 제거할 수 있고, 프탈레이트도 제거하여, 소비자들이 안전하게 섭취할 수 있는 이점이 있으며, 인삼 특유의 쓴맛은 감소하고 부드러운 맛으로 인해 섭취가 용이한 이점이 있다.The ginseng concentrate processed by the method of the present invention can completely remove 320 kinds of pesticide components and also remove phthalates, so consumers can safely consume it, and the characteristic bitter taste of ginseng is reduced and due to its soft taste. It has the advantage of being easy to consume.
본 발명의 목적을 달성하기 위하여, 본 발명은In order to achieve the object of the present invention, the present invention
(1) 인삼에 물 및 글리세린지방산에스테르를 투입한 후 추출하여 인삼 추출액을 제조하는 단계;(1) preparing a ginseng extract by adding water and glycerin fatty acid ester to ginseng and extracting;
(2) 상기 (1)단계의 제조한 인삼 추출액에 식용유를 첨가한 후 교반하는 단계;(2) stirring after adding edible oil to the ginseng extract prepared in step (1);
(3) 상기 (2)단계의 교반한 인삼 오일액을 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거하는 단계;(3) removing the upper oil layer from the ginseng oil liquid separated into an upper oil layer and a lower ginseng extract layer by allowing the stirred ginseng oil liquid of step (2) to stand;
(4) 상기 (3)단계의 오일층을 제거한 인삼 추출액층을 한외여과하는 단계; 및(4) ultra-filtering the ginseng extract layer from which the oil layer of step (3) has been removed; and
(5) 상기 (4)단계의 한외여과한 인삼 추출액을 농축하는 단계를 포함하여 제조하는 것을 특징으로 하는 농약 함량이 저감된 인삼 농축액의 제조방법을 제공한다.(5) provides a method for producing a ginseng concentrate with reduced pesticide content, characterized in that it comprises the step of concentrating the ultra-filtered ginseng extract of the step (4).
본 발명의 인삼 농축액의 제조방법에서, 상기 인삼은 수삼, 홍삼, 건삼, 백삼, 흑삼, 태극삼, 곡삼, 산양삼, 장뇌삼, 산삼배양근, 새싹인삼 및 산삼으로 이루어진 군으로부터 선택되는 하나 이상의 인삼일 수 있으나, 이에 제한되지 않는다.In the method for producing a ginseng concentrate of the present invention, the ginseng may be one or more ginseng selected from the group consisting of fresh ginseng, red ginseng, dried ginseng, white ginseng, black ginseng, Taegeuk ginseng, gok ginseng, wild ginseng, Jangnoe ginseng, wild ginseng cultured root, sprout ginseng, and wild ginseng. , but not limited thereto.
또한, 상기 인삼 대신 한약재, 채소류 및 과실류로 이루어진 군으로부터 선택되는 하나 이상의 재료를 사용할 수 있는데, 보다 구체적으로는 더덕, 오가피, 황칠, 멀꿀, 녹용, 녹각, 동충하초, 마늘, 황금, 양배추, 호박, 석류, 매실 및 대추로 이루어진 군으로부터 선택되는 하나 이상의 재료를 사용할 수 있으나, 이에 한정되는 것은 아니다.In addition, in place of the ginseng, one or more materials selected from the group consisting of herbal medicines, vegetables and fruits may be used, and more specifically, deodeok, sagebrush, hwangchil, mul honey, antler, nokak, cordyceps, garlic, gold, cabbage, pumpkin, At least one material selected from the group consisting of pomegranate, plum, and jujube may be used, but the present invention is not limited thereto.
또한, 본 발명의 인삼 농축액의 제조방법에서, 상기 (1)단계의 인삼 추출액은 바람직하게는 인삼 80~120 g에 물 450~550 mL 및 글리세린지방산에스테르 0.8~1.2 g을 투입하여 60~80℃에서 2~4시간 동안 추출하여 40~45 Brix의 인삼 추출액을 제조할 수 있으며, 더욱 바람직하게는 인삼 100 g에 물 500 mL 및 글리세린지방산에스테르 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 인삼 추출액을 제조할 수 있다.In addition, in the method for producing a ginseng concentrate of the present invention, the ginseng extract of step (1) is preferably 60 to 80 ° C by adding 450 to 550 mL of water and 0.8 to 1.2 g of glycerin fatty acid ester to 80 to 120 g of ginseng. 40 to 45 Brix of ginseng extract can be prepared by extraction for 2 to 4 hours at A ginseng extract of ~45 Brix can be prepared.
또한, 본 발명의 인삼 농축액의 제조방법에서, 상기 (2)단계는 바람직하게는 인삼 추출액에 카놀라유를 8~9:1~2 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반할 수 있으며, 더욱 바람직하게는 인삼 추출액에 카놀라유를 8.5:1.5 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반할 수 있다.In addition, in the method for producing the ginseng concentrate of the present invention, the step (2) is preferably after adding canola oil to the ginseng extract in a volume ratio of 8 to 9: 1 to 2 and then stirring at 30 to 35° C. for 30 to 60 minutes. More preferably, after adding canola oil to the ginseng extract in a volume ratio of 8.5:1.5, the mixture may be stirred at 30 to 35° C. for 30 to 60 minutes.
또한, 상기 오일 첨가 시, 인삼 농축액의 풍미 및 맛을 더욱 향상시키기 위해, 코코넛 오일 및 대추야자유를 추가로 첨가할 수 있는데, 보다 구체적으로는 인삼 추출액에 카놀라유, 코코넛 오일 및 대추 야자유를 8~9:0.8~1.2:0.2~0.4:0.1~0.3 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반할 수 있으며, 더욱 바람직하게는 인삼 추출액에 카놀라유, 코코넛 오일 및 대추 야자유를 8.5:1:0.3:0.2 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반할 수 있다.In addition, when the oil is added, in order to further improve the flavor and taste of the ginseng concentrate, coconut oil and date palm oil may be additionally added. More specifically, 8 to 9 canola oil, coconut oil and date palm oil are added to the ginseng extract. :0.8~1.2:0.2~0.4:0.1~0.3 After adding in a volume ratio, it can be stirred at 30~35℃ for 30~60 minutes, more preferably canola oil, coconut oil and date palm oil in ginseng extract 8.5: After adding in a volume ratio of 1:0.3:0.2, it can be stirred at 30-35° C. for 30-60 minutes.
또한, 본 발명의 인삼 농축액의 제조방법에서, 상기 (3)단계는 바람직하게는 교반한 인삼 오일액을 15~25℃에서 20~28시간 동안 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거할 수 있으며, 더욱 바람직하게는 교반한 인삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거할 수 있다.In addition, in the method for producing a ginseng concentrate of the present invention, in step (3), the stirred ginseng oil solution is preferably left at 15 to 25° C. for 20 to 28 hours, the upper oil layer, and the lower ginseng extract layer The oil layer of the upper layer can be removed from the ginseng oil liquid separated by The upper oil layer can be removed from the oil liquid.
또한, 본 발명의 인삼 농축액의 제조방법에서, 상기 (5)단계는 바람직하게는 한외여과한 인삼 추출액을 60~65℃에서 2~4시간 동안 65~70 Brix로 농축할 수 있으며, 더욱 바람직하게는 한외여과한 인삼 추출액을 60~65℃에서 3시간 동안 65~70 Brix로 농축할 수 있다.In addition, in the method for producing a ginseng concentrate of the present invention, the step (5) may preferably concentrate the ultra-filtered ginseng extract at 60 to 65° C. for 2 to 4 hours to 65 to 70 Brix, more preferably can concentrate the ultra-filtered ginseng extract to 65-70 Brix for 3 hours at 60-65°C.
본 발명의 농약 함량이 저감된 인삼 농축액의 제조방법은, 보다 구체적으로는The method for producing a ginseng concentrate with reduced pesticide content of the present invention, more specifically
(1) 인삼 80~120 g에 물 450~550 mL 및 글리세린지방산에스테르 0.8~1.2 g을 투입하여 60~80℃에서 2~4시간 동안 추출하여 40~45 Brix의 인삼 추출액을 제조하는 단계;(1) preparing a 40-45 Brix ginseng extract by adding 450-550 mL of water and 0.8-1.2 g of glycerin fatty acid ester to 80-120 g of ginseng and extracting it at 60-80°C for 2-4 hours;
(2) 상기 (1)단계의 제조한 인삼 추출액에 카놀라유를 8~9:1~2 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반하는 단계;(2) adding canola oil to the ginseng extract prepared in step (1) in a volume ratio of 8 to 9: 1 to 2, followed by stirring at 30 to 35° C. for 30 to 60 minutes;
(3) 상기 (2)단계의 교반한 인삼 오일액을 15~25℃에서 20~28시간 동안 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거하는 단계;(3) The stirred ginseng oil solution of step (2) was left at 15-25° C. for 20-28 hours, and the upper oil layer was separated from the ginseng oil liquid separated into the upper oil layer and the lower ginseng extract layer. removing;
(4) 상기 (3)단계의 오일층을 제거한 인삼 추출액층을 한외여과하는 단계; 및(4) ultra-filtering the ginseng extract layer from which the oil layer of step (3) has been removed; and
(5) 상기 (4)단계의 한외여과한 인삼 추출액을 60~65℃에서 2~4시간 동안 65~70 Brix로 농축하는 단계를 포함할 수 있으며,(5) may include the step of concentrating the ultra-filtered ginseng extract of step (4) to 65-70 Brix at 60-65° C. for 2-4 hours,
더욱 구체적으로는more specifically
(1) 인삼 100 g에 물 500 mL 및 글리세린지방산에스테르 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 인삼 추출액을 제조하는 단계;(1) preparing a ginseng extract of 40-45 Brix by adding 500 mL of water and 1 g of glycerin fatty acid ester to 100 g of ginseng and extracting it at 70° C. for 3 hours;
(2) 상기 (1)단계의 제조한 인삼 추출액에 카놀라유를 8.5:1.5 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반하는 단계;(2) adding canola oil to the ginseng extract prepared in step (1) in a volume ratio of 8.5:1.5 and stirring at 30 to 35° C. for 30 to 60 minutes;
(3) 상기 (2)단계의 교반한 인삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거하는 단계;(3) removing the upper oil layer from the ginseng oil liquid separated into an upper oil layer and a lower ginseng extract layer by allowing the stirred ginseng oil solution of step (2) to stand at 20° C. for 24 hours;
(4) 상기 (3)단계의 오일층을 제거한 인삼 추출액층을 한외여과하는 단계; 및(4) ultra-filtering the ginseng extract layer from which the oil layer of step (3) has been removed; and
(5) 상기 (4)단계의 한외여과한 인삼 추출액을 60~65℃에서 3시간 동안 65~70 Brix로 농축하는 단계를 포함할 수 있다.(5) It may include the step of concentrating the ultra-filtered ginseng extract of step (4) to 65-70 Brix at 60-65° C. for 3 hours.
본 발명은 또한, 상기 방법으로 제조된 농약 함량이 저감된 인삼 농축액을 제공한다.The present invention also provides a ginseng concentrate with reduced pesticide content prepared by the above method.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples only illustrate the present invention, and the content of the present invention is not limited to the following examples.
제조예 1. 홍삼 농축액(글리세린지방산에스테르-식용유-한외여과 처리)Preparation Example 1. Red ginseng concentrate (glycerin fatty acid ester-edible oil-ultrafiltration treatment)
(1) 홍삼 100 g에 정제수 500 mL 및 글리세린지방산에스테르(Glycerin Esters of Fatty Acids, GEFA) 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 500 mL of purified water and 1 g of glycerin fatty acid esters (Glycerin Esters of Fatty Acids, GEFA) were added to 100 g of red ginseng, and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액에 카놀라유를 9:1 부피비율로 첨가한 후 펌프로 서큘레이션하면서 30~35℃에서 45 rpm으로 30~60분 동안 교반하였다.(2) After adding canola oil to the red ginseng extract prepared in step (1) at a volume ratio of 9:1, the mixture was circulated with a pump and stirred at 30 to 35° C. at 45 rpm for 30 to 60 minutes.
(3) 상기 (2)단계의 교반한 홍삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 홍삼 추출액층으로 분리된 홍삼 오일액에서 상층의 오일층을 제거하였다.(3) The stirred red ginseng oil solution of step (2) was left at 20° C. for 24 hours, and the upper oil layer was removed from the red ginseng oil solution separated into an upper oil layer and a lower red ginseng extract layer.
(4) 상기 (3)단계의 오일층을 제거한 홍삼 추출액층을 한외여과하였다.(4) The red ginseng extract layer from which the oil layer of step (3) was removed was ultra-filtered.
이때 한외여과에서 사용되는 막은 셀룰로오스 아세테이트, 폴리에테르설폰 중 적어도 하나를 사용하였고, 막의 구멍 크기 0.1~0.3 ㎛, 피드(feed) 압력은 5~20 bar, 실온 조건에서 수행하였다. 한외여과 공정은 50 ㎛의 체에 1차로 여과한 후, 30 ㎛의 체에 2차로 여과하고, 20℃로 냉각하였고, 20 ㎛의 체에 3차로 여과한 후, 다시 2℃로 냉각하고, 0.1 ㎛의 체에 4차로 여과하는 다단 여과 공정을 실시하였다.At this time, the membrane used in the ultrafiltration used at least one of cellulose acetate and polyethersulfone, the membrane pore size was 0.1 to 0.3 μm, the feed pressure was 5 to 20 bar, and it was carried out at room temperature. The ultrafiltration process was first filtered through a 50 μm sieve, then secondarily filtered through a 30 μm sieve, cooled to 20° C., filtered thirdly through a 20 μm sieve, and then cooled to 2° C. again, 0.1 A multi-stage filtration step of filtration through a sieve of μm was performed.
(5) 상기 (4)단계의 한외여과한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(5) The ultra-filtered red ginseng extract of step (4) was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
제조예 2. 홍삼 농축액(글리세린지방산에스테르-식용유-한외여과 처리)Preparation Example 2. Red ginseng concentrate (glycerin fatty acid ester-edible oil-ultrafiltration treatment)
(1) 홍삼 100 g에 정제수 500 mL 및 글리세린지방산에스테르(Glycerin Esters of Fatty Acids, GEFA) 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 500 mL of purified water and 1 g of glycerin fatty acid esters (Glycerin Esters of Fatty Acids, GEFA) were added to 100 g of red ginseng, and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액에 카놀라유, 코코넛 오일 및 대추 야자유를 8.5:1:0.3:0.2 부피비율로 첨가한 후 펌프로 서큘레이션하면서 30~35℃에서 45 rpm으로 30~60분 동안 교반하였다.(2) After adding canola oil, coconut oil, and date palm oil in a volume ratio of 8.5:1:0.3:0.2 to the red ginseng extract prepared in step (1), circulating with a pump at 30-35°C at 45 rpm for 30- Stir for 60 minutes.
(3) 상기 (2)단계의 교반한 홍삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 홍삼 추출액층으로 분리된 홍삼 오일액에서 상층의 오일층을 제거하였다.(3) The stirred red ginseng oil solution of step (2) was left at 20° C. for 24 hours, and the upper oil layer was removed from the red ginseng oil solution separated into an upper oil layer and a lower red ginseng extract layer.
(4) 상기 (3)단계의 오일층을 제거한 홍삼 추출액층을 한외여과하였다.(4) The red ginseng extract layer from which the oil layer of step (3) was removed was ultra-filtered.
이때 한외여과에서 사용되는 막은 셀룰로오스 아세테이트, 폴리에테르설폰 중 적어도 하나를 사용하였고, 막의 구멍 크기 0.1~0.3 ㎛, 피드(feed) 압력은 5~20 bar, 실온 조건에서 수행하였다. 한외여과 공정은 50 ㎛의 체에 1차로 여과한 후, 30 ㎛의 체에 2차로 여과하고, 20℃로 냉각하였고, 20 ㎛의 체에 3차로 여과한 후, 다시 2℃로 냉각하고, 0.1 ㎛의 체에 4차로 여과하는 다단 여과 공정을 실시하였다.At this time, the membrane used in the ultrafiltration used at least one of cellulose acetate and polyethersulfone, the membrane pore size was 0.1 to 0.3 μm, the feed pressure was 5 to 20 bar, and it was carried out at room temperature. The ultrafiltration process was first filtered through a 50 μm sieve, then secondarily filtered through a 30 μm sieve, cooled to 20° C., filtered thirdly through a 20 μm sieve, and then cooled to 2° C. again, 0.1 A multi-stage filtration step of filtration through a sieve of μm was performed.
(5) 상기 (4)단계의 한외여과한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(5) The ultra-filtered red ginseng extract of step (4) was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
대조군. 홍삼 농축액control group. Red Ginseng Concentrate
(1) 홍삼 100 g에 정제수 500 mL를 첨가하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 100 g of red ginseng was added with 500 mL of purified water and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(2) The red ginseng extract prepared in step (1) was concentrated at 60-65° C. at a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
비교예 1. 홍삼 농축액(글리세린지방산에스테르 처리)Comparative Example 1. Red ginseng concentrate (glycerin fatty acid ester treatment)
(1) 홍삼 100 g에 정제수 500 mL 및 글리세린지방산에스테르(Glycerin Esters of Fatty Acids, GEFA) 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 500 mL of purified water and 1 g of glycerin fatty acid esters (Glycerin Esters of Fatty Acids, GEFA) were added to 100 g of red ginseng, and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(2) The red ginseng extract prepared in step (1) was concentrated at 60-65° C. at a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
비교예 2. 홍삼 농축액(식용유 처리)Comparative Example 2. Red ginseng concentrate (cooking oil treatment)
(1) 홍삼 100 g에 정제수 500 mL를 첨가하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 100 g of red ginseng was added with 500 mL of purified water and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액에 카놀라유를 9:1 부피비율로 첨가한 후 펌프로 서큘레이션하면서 20℃에서 45 rpm으로 30~60분 동안 교반하였다.(2) After adding canola oil to the red ginseng extract prepared in step (1) in a volume ratio of 9:1, it was stirred at 20° C. at 45 rpm for 30 to 60 minutes while circulating with a pump.
(3) 상기 (2)단계의 교반한 홍삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 홍삼 추출액층으로 분리된 홍삼 오일액에서 상층의 오일층을 제거하였다.(3) The stirred red ginseng oil solution of step (2) was left at 20° C. for 24 hours, and the upper oil layer was removed from the red ginseng oil solution separated into an upper oil layer and a lower red ginseng extract layer.
(4) 상기 (3)단계의 오일층을 제거한 홍삼 추출액층을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(4) The red ginseng extract layer from which the oil layer of step (3) was removed was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
비교예 3. 홍삼 농축액(한외여과 처리)Comparative Example 3. Red ginseng concentrate (ultrafiltration treatment)
(1) 홍삼 100 g에 정제수 500 mL를 첨가하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 100 g of red ginseng was added with 500 mL of purified water and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액을 한외여과하였다.(2) The red ginseng extract prepared in step (1) was ultra-filtered.
이때 한외여과에서 사용되는 막은 셀룰로오스 아세테이트, 폴리에테르설폰 중 적어도 하나를 사용하였고, 막의 구멍 크기 0.1~0.3 ㎛, 피드(feed) 압력은 5~20 bar, 실온 조건에서 수행하였다. 한외여과 공정은 50 ㎛의 체에 1차로 여과한 후, 30 ㎛의 체에 2차로 여과하고, 20℃로 냉각하였고, 20 ㎛의 체에 3차로 여과한 후, 다시 2℃로 냉각하고, 0.1 ㎛의 체에 4차로 여과하는 다단 여과 공정을 실시하였다.At this time, the membrane used in the ultrafiltration used at least one of cellulose acetate and polyethersulfone, the membrane pore size was 0.1 to 0.3 μm, the feed pressure was 5 to 20 bar, and it was carried out at room temperature. The ultrafiltration process was first filtered through a 50 μm sieve, then secondarily filtered through a 30 μm sieve, cooled to 20° C., filtered thirdly through a 20 μm sieve, and then cooled to 2° C. again, 0.1 A multi-stage filtration step of filtration through a sieve of μm was performed.
(3) 상기 (2)단계의 한외여과한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(3) The ultra-filtered red ginseng extract of step (2) was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
비교예 4. 홍삼 농축액(글리세린지방산에스테르-식용유 처리)Comparative Example 4. Red ginseng concentrate (glycerin fatty acid ester-cooking oil treatment)
(1) 홍삼 100 g에 정제수 500 mL 및 글리세린지방산에스테르(Glycerin Esters of Fatty Acids, GEFA) 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 500 mL of purified water and 1 g of glycerin fatty acid esters (Glycerin Esters of Fatty Acids, GEFA) were added to 100 g of red ginseng, and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액에 카놀라유를 9:1 부피비율로 첨가한 후 펌프로 서큘레이션하면서 20℃에서 45 rpm으로 30~60분 동안 교반하였다.(2) After adding canola oil to the red ginseng extract prepared in step (1) in a volume ratio of 9:1, it was stirred at 20° C. at 45 rpm for 30 to 60 minutes while circulating with a pump.
(3) 상기 (2)단계의 교반한 홍삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 홍삼 추출액층으로 분리된 홍삼 오일액에서 상층의 오일층을 제거하였다.(3) The stirred red ginseng oil solution of step (2) was left at 20° C. for 24 hours, and the upper oil layer was removed from the red ginseng oil solution separated into an upper oil layer and a lower red ginseng extract layer.
(4) 상기 (3)단계의 오일층을 제거한 홍삼 추출액층을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(4) The red ginseng extract layer from which the oil layer of step (3) was removed was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
비교예 5. 홍삼 농축액(글리세린지방산에스테르-한외여과 처리)Comparative Example 5. Red ginseng concentrate (glycerin fatty acid ester-ultrafiltration treatment)
(1) 홍삼 100 g에 정제수 500 mL 및 글리세린지방산에스테르(Glycerin Esters of Fatty Acids, GEFA) 1 g을 투입하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 500 mL of purified water and 1 g of glycerin fatty acid esters (Glycerin Esters of Fatty Acids, GEFA) were added to 100 g of red ginseng, and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액을 한외여과하였다.(2) The red ginseng extract prepared in step (1) was ultra-filtered.
이때 한외여과에서 사용되는 막은 셀룰로오스 아세테이트, 폴리에테르설폰 중 적어도 하나를 사용하였고, 막의 구멍 크기 0.1~0.3 ㎛, 피드(feed) 압력은 5~20 bar, 실온 조건에서 수행하였다. 한외여과 공정은 50 ㎛의 체에 1차로 여과한 후, 30 ㎛의 체에 2차로 여과하고, 20℃로 냉각하였고, 20 ㎛의 체에 3차로 여과한 후, 다시 2℃로 냉각하고, 0.1 ㎛의 체에 4차로 여과하는 다단 여과 공정을 실시하였다.At this time, the membrane used in the ultrafiltration used at least one of cellulose acetate and polyethersulfone, the membrane pore size was 0.1 to 0.3 μm, the feed pressure was 5 to 20 bar, and it was carried out at room temperature. The ultrafiltration process was first filtered through a 50 μm sieve, then secondarily filtered through a 30 μm sieve, cooled to 20° C., filtered thirdly through a 20 μm sieve, and then cooled to 2° C. again, 0.1 A multi-stage filtration step of filtration through a sieve of μm was performed.
(3) 상기 (2)단계의 한외여과한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(3) The ultra-filtered red ginseng extract of step (2) was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
비교예 6. 홍삼 농축액(식용유-한외여과 처리)Comparative Example 6. Red ginseng concentrate (edible oil-ultrafiltration treatment)
(1) 홍삼 100 g에 정제수 500 mL를 첨가하여 70℃에서 3시간 동안 추출하여 40~45 Brix의 홍삼 추출액을 제조하였다.(1) 100 g of red ginseng was added with 500 mL of purified water and extracted at 70° C. for 3 hours to prepare a 40-45 Brix red ginseng extract.
(2) 상기 (1)단계의 제조한 홍삼 추출액에 카놀라유를 9:1 부피비율로 첨가한 후 펌프로 서큘레이션하면서 20℃에서 45 rpm으로 30~60분 동안 교반하였다.(2) After adding canola oil to the red ginseng extract prepared in step (1) in a volume ratio of 9:1, it was stirred at 20° C. at 45 rpm for 30 to 60 minutes while circulating with a pump.
(3) 상기 (2)단계의 교반한 홍삼 오일액을 20℃에서 24시간 동안 정치하여, 상층의 오일층, 하층의 홍삼 추출액층으로 분리된 홍삼 오일액에서 상층의 오일층을 제거하였다.(3) The stirred red ginseng oil solution of step (2) was left at 20° C. for 24 hours, and the upper oil layer was removed from the red ginseng oil solution separated into an upper oil layer and a lower red ginseng extract layer.
(4) 상기 (3)단계의 오일층을 제거한 홍삼 추출액층을 한외여과하였다.(4) The red ginseng extract layer from which the oil layer of step (3) was removed was ultra-filtered.
이때 한외여과에서 사용되는 막은 셀룰로오스 아세테이트, 폴리에테르설폰 중 적어도 하나를 사용하였고, 막의 구멍 크기 0.1~0.3 ㎛, 피드(feed) 압력은 5~20 bar, 실온 조건에서 수행하였다. 한외여과 공정은 50 ㎛의 체에 1차로 여과한 후, 30 ㎛의 체에 2차로 여과하고, 20℃로 냉각하였고, 20 ㎛의 체에 3차로 여과한 후, 다시 2℃로 냉각하고, 0.1 ㎛의 체에 4차로 여과하는 다단 여과 공정을 실시하였다.At this time, the membrane used in the ultrafiltration used at least one of cellulose acetate and polyethersulfone, the membrane pore size was 0.1 to 0.3 μm, the feed pressure was 5 to 20 bar, and it was carried out at room temperature. The ultrafiltration process was first filtered through a 50 μm sieve, then secondarily filtered through a 30 μm sieve, cooled to 20° C., filtered thirdly through a 20 μm sieve, and then cooled to 2° C. again, 0.1 A multi-stage filtration step of filtration through a sieve of μm was performed.
(5) 상기 (4)단계의 한외여과한 홍삼 추출액을 60~65℃에서 600~670 mmHg의 압력으로 3시간 동안 농축하여 65~70 Brix의 홍삼 농축액을 제조하였다.(5) The ultra-filtered red ginseng extract of step (4) was concentrated at 60-65° C. under a pressure of 600-670 mmHg for 3 hours to prepare a 65-70 Brix red ginseng concentrate.
실험방법Experimental method
1. 질량분석기에 의한 잔류농약 분석1. Analysis of pesticide residues by mass spectrometer
가. LC-MS/MS(액체 크로마토그래프 질량분석기)에 의한 분석go. Analysis by LC-MS/MS (Liquid Chromatograph Mass Spectrometer)
각각의 방법으로 제조한 홍삼 농축액 5 g을 정밀히 달아 50 mL 원심분리관에 넣고 내부표준물질(0.1 mg/L triphenylphosphate)을 함유한 아세토니트릴 10 mL를 넣은 후 1~2분간 진탕하였다.5 g of the red ginseng concentrate prepared by each method was precisely weighed, put into a 50 mL centrifuge tube, 10 mL of acetonitrile containing an internal standard (0.1 mg/L triphenylphosphate) was added, and then shaken for 1-2 minutes.
상기액을 원심분리관에 무수황산마그네슘 4.0(±0.2) g, 염화나트륨 1.0(±0.05) g, 구연산나트륨이수화물 1.0(±0.05) g, disodium hydrogencitrate sesquihydrate 0.5(±0.03) g을 넣고 1분간 상하 좌우로 흔들어 혼합한 후, 원심분리(3,000 rpm/min, 5분)하여 아세토니트릴층과 물층을 분리시킨 후 아세토니트릴층을 LC-MS/MS 시료추출액으로 사용하였다.Add 4.0(±0.2) g of anhydrous magnesium sulfate, 1.0(±0.05) g of sodium chloride, 1.0(±0.05) g of sodium citrate dihydrate, and 0.5(±0.03) g of disodium hydrogencitrate sesquihydrate to the solution in a centrifuge tube, and put it up and down for 1 minute. After mixing by shaking left and right, centrifugation (3,000 rpm/min, 5 minutes) was performed to separate the acetonitrile layer and the water layer, and then the acetonitrile layer was used as an LC-MS/MS sample extract.
600 ㎕ +
아세토니트릴
200 ㎕buffer solution
600 μl +
acetonitrile
200 μl
600 ㎕ +
아세토니트릴
200 ㎕buffer solution
600 μl +
acetonitrile
200 μl
600 ㎕ +
아세토니트릴
200 ㎕buffer solution
600 μl +
acetonitrile
200 μl
600 ㎕ +
아세토니트릴
200 ㎕buffer solution
600 μl +
acetonitrile
200 μl
아세토니트릴
300 ㎕Buffer 600 μl+
acetonitrile
300 μl
10 ㎍/L
×100 ㎕STD
10 μg/L
×100 μl
50 ㎍/L
×100 ㎕STD
50 μg/L
×100 μl
200 ㎍/L
×100 ㎕STD
200 μg/L
×100 μl
500 ㎍/L
×100 ㎕STD
500 μg/L
×100 μl
100 ㎕Pesticide-free sample extract
100 μl
100 ㎕Pesticide-free sample extract
100 μl
100 ㎕Pesticide-free sample extract
100 μl
100 ㎕Pesticide-free sample extract
100 μl
100 ㎕sample extract
100 μl
B 이동상: 0.1% 포름산과 5 mM 포름산암모늄 함유 메탄올 용액A mobile phase: aqueous solution containing 0.1% formic acid and 5 mM ammonium formate
B Mobile phase: Methanol solution containing 0.1% formic acid and 5 mM ammonium formate
나. GC-MS/MS(기체 크로마토그래프 질량분석기)에 의한 분석me. Analysis by GC-MS/MS (Gas Chromatograph Mass Spectrometer)
각각의 방법으로 제조한 홍삼 농축액 5 g을 정밀히 달아 50 mL 원심분리관에 넣고 내부표준물질(0.1 mg/L triphenylphosphate)을 함유한 아세토니트릴 10 mL를 넣은 후 1~2분간 진탕하였다.5 g of the red ginseng concentrate prepared by each method was precisely weighed, put into a 50 mL centrifuge tube, 10 mL of acetonitrile containing an internal standard (0.1 mg/L triphenylphosphate) was added, and then shaken for 1-2 minutes.
상기액을 원심분리관에 무수황산마그네슘 4.0(±0.2) g, 염화나트륨 1.0(±0.05) g, 구연산나트륨이수화물 1.0(±0.05) g, disodium hydrogencitrate sesquihydrate 0.5(±0.03) g을 넣고 1분간 상하 좌우로 흔들어 혼합한 후, 원심분리(3,000 rpm/min, 5분)하여 아세토니트릴층과 물층을 분리시킨 후 아세토니트릴층을 분리하였다. 아세토니트릴층분리액을 PSA 25 mg와 무수황산마그네슘 150 mg을 넣어둔 분상고체상 추출 튜브에 넣고 1분간 진탕 후 원심분리(10,000 rpm/min, 2분)한 다음 멤브레인 필터(0.2 ㎛)로 여과하여 GC-MS/MS 시료 추출액으로 사용하였다. Add 4.0(±0.2) g of anhydrous magnesium sulfate, 1.0(±0.05) g of sodium chloride, 1.0(±0.05) g of sodium citrate dihydrate, and 0.5(±0.03) g of disodium hydrogencitrate sesquihydrate to the solution in a centrifuge tube, and put it up and down for 1 minute. After mixing by shaking left and right, centrifugation (3,000 rpm/min, 5 minutes) was performed to separate the acetonitrile layer and the water layer, and then the acetonitrile layer was separated. The acetonitrile layer separation solution was placed in a powder-phase extraction tube containing 25 mg of PSA and 150 mg of anhydrous magnesium sulfate, shaken for 1 minute, centrifuged (10,000 rpm/min, 2 minutes), and filtered through a membrane filter (0.2 μm). It was used as a GC-MS/MS sample extract.
1000 ㎍/L
×50 ㎕internal standard material
1000 μg/L
×50 μl
1000 ㎍/L
×50 ㎕internal standard material
1000 μg/L
×50 μl
1000 ㎍/L
×50 ㎕internal standard material
1000 μg/L
×50 μl
1000 ㎍/L
×50 ㎕internal standard material
1000 μg/L
×50 μl
75 ㎕acetonitrile
75 μl
200 ㎍/L
×25 ㎕STD
200 μg/L
×25 μl
1,000 ㎍/L
×25 ㎕STD
1,000 μg/L
×25 μl
4,000 ㎍/L
×25 ㎕STD
4,000 μg/L
×25 μl
10,000 ㎍/L
×25 ㎕STD
10,000 μg/L
×25 μl
405 ㎕Pesticide-free sample extract
405 μl
405 ㎕Pesticide-free sample extract
405 μl
405 ㎕Pesticide-free sample extract
405 μl
405 ㎕Pesticide-free sample extract
405 μl
405 ㎕sample extract
405 μl
2. GC-MS(기체 크로마토그래프 질량분석기)에 의한 프탈레이트 분석2. Phthalate analysis by GC-MS (Gas Chromatograph Mass Spectrometer)
각각의 홍삼 농축액 25 g을 취하여 분액여두에 옮기고 아세톤, 헥산 혼합액 1:1(v/v) 50 mL를 가하여 5분간 격렬하게 진탕한 후 정치하여 아세톤, 헥산층을 250 mL 플라스크에 옮겼다. 남은 여액에 아세톤, 헥산 혼합액 50 mL를 가하고 위와 동일하게 2회 조작하여 아세톤, 헥산층을 위의 플라스크에 합하여 감압농축한 후 잔류물을 아세톤에 녹여 5 mL로 한 액을 시험용액으로 하였다.Take 25 g of each red ginseng concentrate, transfer it to a separatory funnel, add 50 mL of a 1:1 (v/v) mixture of acetone and hexane, shake vigorously for 5 minutes, and then stand still, and transfer the acetone and hexane layers to a 250 mL flask. To the remaining filtrate, 50 mL of a mixed solution of acetone and hexane was added, and the same operation was repeated twice. The acetone and hexane layers were combined in the flask above and concentrated under reduced pressure. Then, the residue was dissolved in acetone to make 5 mL, and the solution was used as the test solution.
80℃에서 시료액을 주입하고 0.5분간 유지한 후 200℃/min 비율로 280℃까지 상승시켜 29분간 유지
split ratio는 초기 조건 20:1, splitless 0.5분간 유지 후 1.5분 split ratio를 50:1로 설정Programmed Temperature Vaporizer (PTV) or equivalent
After injecting the sample solution at 80°C and holding it for 0.5 minutes, increase it to 280°C at the rate of 200°C/min and keep it for 29 minutes
The split ratio is set to 50:1 for 1.5 minutes after maintaining the initial condition 20:1, splitless for 0.5 minutes
- scan time: 약 1초
- Mass peak width: quad1(1.5 m/z), quad3(2.5 m/z)
- Transfer line: 280℃, Manifold: 40℃, Ion source: 230℃Electron multiplier voltage : 1,100 V
- scan time: about 1 second
- Mass peak width: quad1 (1.5 m/z), quad3 (2.5 m/z)
- Transfer line: 280℃, Manifold: 40℃, Ion source: 230℃
실시예 1. 공정처리 전후 잔류농약 함량Example 1. Residual pesticide content before and after processing
공정처리에 따른 홍삼 농축액의 320종에 대한 잔류농약 함량을 비교한 결과는 하기 표 7 내지 17과 같다. The results of comparing the residual pesticide content of 320 kinds of red ginseng concentrate according to the process treatment are shown in Tables 7 to 17 below.
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
(대조군Residual amount before treatment
(control group
(대조군)Residual amount before treatment
(control group)
(대조군)Residual amount before treatment
(control group)
실시예 2. 공정처리 전후 프탈레이트 함량Example 2. Phthalate content before and after processing
공정처리에 따른 홍삼 농축액의 2종에 대한 프탈레이트 함량을 비교한 결과는 하기 표 18과 같다. 그 결과, 제조예 1의 공정처리한 홍삼 농축액은 하기 2종의 프탈레이트를 완전히 제거하였다.The results of comparing the phthalate content of two types of red ginseng concentrate according to the process treatment are shown in Table 18 below. As a result, the process-treated red ginseng concentrate of Preparation Example 1 completely removed the following two types of phthalates.
(대조군)Residual amount before treatment
(control group)
실시예 3. 공정처리 전후 잔류농약 함량Example 3. Residual pesticide content before and after processing
공정처리 단계에 따른 홍삼 농축액의 35종에 대한 잔류농약 함량을 비교한 결과는 하기 표 19 및 20과 같다. 그 결과, 제조예 1과 같이, 글리세린지방산에스테르 처리, 식용유 처리 및 한외여과 처리를 모두 거쳐 홍삼 농축액을 제조하는 것이 잔류농약 저감 효과가 가장 우수하였다.The results of comparing the residual pesticide content of 35 kinds of red ginseng concentrate according to the processing steps are shown in Tables 19 and 20 below. As a result, as in Preparation Example 1, the preparation of a red ginseng concentrate through glycerin fatty acid ester treatment, edible oil treatment, and ultrafiltration treatment was the most effective in reducing pesticide residues.
(대조군)Residual amount of untreated group
(control group)
(제조예 1)3 step processing
(Production Example 1)
(비교예 1)Step 1 single processing
(Comparative Example 1)
(비교예 2)2nd stage single processing
(Comparative Example 2)
(비교예 3)3 step single processing
(Comparative Example 3)
(ppm)residual amount
(ppm)
(대조군)Residual amount of untreated group
(control group)
(제조예 1)3 step processing
(Production Example 1)
(비교예 4)Stage 1 processing, then stage 2 processing
(Comparative Example 4)
(비교예 5)Stage 1 processing, then stage 3 processing
(Comparative Example 5)
(비교예 6)Step 2 processing, then step 3 processing
(Comparative Example 6)
(ppm)residual amount
(ppm)
실시예 8. 식용유 처리한 홍삼 추출액층의 관능평가Example 8. Sensory evaluation of edible oil-treated red ginseng extract layer
홍삼 추출액에 식용유 처리 시 식용유 종류를 달리하여 제조한 홍삼 추출액층을 가지고 성인 40명을 대상으로 섭취하게 하였다. 선호도는 대조군과 가까울수록 5점에 가깝게 평가하도록 하였고, 이미 및 이취는 아주 나쁠 경우 1점, 아주 좋을 경우 5점으로 하여 평가하도록 하였다.When red ginseng extract was treated with edible oil, 40 adults were ingested with a layer of red ginseng extract prepared by different types of edible oil. Preference was evaluated to be closer to 5 points as it was closer to the control group, and taste and odor were evaluated as 1 point when very bad and 5 points when very good.
그 결과, 모든 식용유에서 잔류농약과 프탈레이트는 90% 이상 제거되어 제거율에서는 차이가 없었으나, 관능적으로 무처리군에 가까운 것은 카놀라유, 카놀라유+코코넛오일, 카놀라유+코코넛오일+대추야자유 처리구로 나타났다.As a result, more than 90% of pesticides and phthalates were removed from all cooking oils, so there was no difference in the removal rate.
또한, 이미 및 이취에서 무처리군에 비해서 카놀라유+코코넛오일+대추야자유를 모두 첨가하는 것이 기호도가 개선됨을 확인하였다.In addition, it was confirmed that the addition of both canola oil + coconut oil + date palm oil improved the preference compared to the untreated group in the rice and odor.
실시예 9: 홍삼 농축액의 관능평가Example 9: Sensory evaluation of red ginseng concentrate
각각의 가공처리된 홍삼 농축액을 가지고 성인 40명을 대상으로 섭취하게 한 후, 선호도가 높을수록 5점에 가깝게 평가하도록 하여 평균으로 나눈 값은 하기 표 22과 같다.After ingesting 40 adults with each processed red ginseng concentrate, the higher the preference, the closer to 5 points, and the value divided by the average is shown in Table 22 below.
그 결과, 무처리군(대조군)에 비해 더 개선된 관능을 지니는 홍삼 농축액은 제조예 1 및 2로 나타났다.As a result, the red ginseng concentrate having a more improved sensory compared to the untreated group (control group) was shown in Preparation Examples 1 and 2.
Claims (5)
(2) 상기 (1)단계의 제조한 인삼 추출액에 카놀라유, 코코넛 오일 및 대추 야자유를 8~9:0.8~1.2:0.2~0.4:0.1~0.3 부피비율로 첨가한 후 30~35℃에서 30~60분 동안 교반하는 단계;
(3) 상기 (2)단계의 교반한 인삼 오일액을 15~25℃에서 20~28시간 동안 정치하여, 상층의 오일층, 하층의 인삼 추출액층으로 분리된 인삼 오일액에서 상층의 오일층을 제거하는 단계;
(4) 상기 (3)단계의 오일층을 제거한 인삼 추출액층을 한외여과하는 단계; 및
(5) 상기 (4)단계의 한외여과한 인삼 추출액을 60~65℃에서 2~4시간 동안 65~70 Brix로 농축하는 단계를 포함하여 제조하는 것을 특징으로 하는 농약 함량이 저감된 인삼 농축액의 제조방법.(1) preparing a 40-45 Brix ginseng extract by adding 450-550 mL of water and 0.8-1.2 g of glycerin fatty acid ester to 80-120 g of ginseng and extracting it at 60-80°C for 2-4 hours;
(2) After adding canola oil, coconut oil and date palm oil to the ginseng extract prepared in step (1) in a volume ratio of 8~9:0.8~1.2:0.2~0.4:0.1~0.3, 30~ at 30~35℃ stirring for 60 minutes;
(3) The stirred ginseng oil solution of step (2) is left at 15-25° C. for 20-28 hours, and the upper oil layer is separated from the ginseng oil solution separated into the upper oil layer and the lower ginseng extract layer. removing;
(4) ultra-filtering the ginseng extract layer from which the oil layer of step (3) has been removed; and
(5) of the ginseng concentrate with reduced pesticide content, characterized in that it comprises the step of concentrating the ultra-filtered ginseng extract of the step (4) to 65-70 Brix at 60-65 ° C. for 2-4 hours manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210167489A KR102388736B1 (en) | 2021-11-29 | 2021-11-29 | Method for removing residual pesticide in natural plant extract by three stage treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210167489A KR102388736B1 (en) | 2021-11-29 | 2021-11-29 | Method for removing residual pesticide in natural plant extract by three stage treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102388736B1 true KR102388736B1 (en) | 2022-04-20 |
Family
ID=81395521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210167489A KR102388736B1 (en) | 2021-11-29 | 2021-11-29 | Method for removing residual pesticide in natural plant extract by three stage treatment |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102388736B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07123916A (en) * | 1993-11-06 | 1995-05-16 | Taiyo Kagaku Co Ltd | Treatment of vegetable |
US5906848A (en) * | 1995-03-06 | 1999-05-25 | Emil Flachsmann Ag | Process for the removal of undesired contaminations and/or residues contained in beverages or in vegetable preparation |
KR20200016113A (en) * | 2018-08-06 | 2020-02-14 | 세명대학교 산학협력단 | Pesticide-removed crude drug extract through ultrasonic thermal fusion treatment and process for thereof |
-
2021
- 2021-11-29 KR KR1020210167489A patent/KR102388736B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07123916A (en) * | 1993-11-06 | 1995-05-16 | Taiyo Kagaku Co Ltd | Treatment of vegetable |
US5906848A (en) * | 1995-03-06 | 1999-05-25 | Emil Flachsmann Ag | Process for the removal of undesired contaminations and/or residues contained in beverages or in vegetable preparation |
KR20200016113A (en) * | 2018-08-06 | 2020-02-14 | 세명대학교 산학협력단 | Pesticide-removed crude drug extract through ultrasonic thermal fusion treatment and process for thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nambiar et al. | Microencapsulation of tender coconut water by spray drying: effect of Moringa oleifera gum, maltodextrin concentrations, and inlet temperature on powder qualities | |
Mastovska et al. | Pesticide multiresidue analysis in cereal grains using modified QuEChERS method combined with automated direct sample introduction GC-TOFMS and UPLC-MS/MS techniques | |
Urkude et al. | Pesticide residues in beverages | |
EP2196098B1 (en) | Aroma substances included in cellulose | |
AU2016271765B2 (en) | Agrochemical-free siraitia grosvenorii extract, and method for preparing same | |
Calvo et al. | Fractionation of biologically active components of grape seed (Vitis vinifera) by supercritical fluid extraction | |
Lim et al. | Microencapsulation of phenolic compounds from waste mango seed kernel extract by spray drying technology | |
KR102388736B1 (en) | Method for removing residual pesticide in natural plant extract by three stage treatment | |
AU2012245358B2 (en) | Encapsulation of extract in porous particles | |
CN116392461A (en) | Lutein composition with enhanced bioavailability comprising lutein and zeaxanthin | |
Demircan et al. | Bergamot juice powder with high bioactive properties: Spray‐drying for the preservation of antioxidant activity and ultrasound‐assisted extraction for enhanced phenolic compound extraction | |
JPH09143465A (en) | Antioxidative composition | |
Zhang et al. | Distribution, migration and changes of typical chemical preservatives on orange during storage and processing | |
KR102104923B1 (en) | Pesticide-removed crude drug extract through ultrasonic thermal fusion treatment and process for thereof | |
KR102376179B1 (en) | Method for producing ginseng concentrate with reduced pesticide and phthalate | |
Oussou et al. | Valorization of cocoa, tea and coffee processing by-products-wastes | |
KR100751948B1 (en) | Method for production of fat removal-edible powder and fat removal-edible powder thereof | |
Cunha et al. | Application in Food Analysis | |
KR101784866B1 (en) | Flavor enhanced flavor oil powder and manufacturing method thereof | |
Eticha | Review: Sample Preparation Methods for the Pesticide Residue Analysis in Food Samples | |
Osman et al. | Spray drying of roselle-pineapple juice effects of inlet temperature and maltodextrin on the physical properties | |
KR100522931B1 (en) | Method for production of fat removal sesame powder from sesame and fat removal powder thereof | |
KR20210011858A (en) | A method for removing pesticide residues from ginseng leaves and preparation of composition comprising Compound K | |
WO2021005239A1 (en) | Method for the recovery or enrichment of flavours of fragrances from an aroma-laden gas phase and an aroma concentrate | |
KR20060118220A (en) | Method for production of fat removal powder from raw materials of edible oil and fat removal powder thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |